Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1050.Time spend outdoors in summer,44945,0.0296458776950792,0.0351520082463255,-0.0392520584677187,0.0985438138578771,0.399035707007541
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1060.Time spent outdoors in winter,41824,0.0613314775802766,0.0404871485638408,-0.0180233336048514,0.140686288765405,0.129831588976564
LYZL2,Lysozyme-like protein 2,Physical activities,X1070.Time spent watching television (TV),46255,0.00870237748937865,0.0362647832058269,-0.0623765975940421,0.0797813525727994,0.810357534112956
LYZL2,Lysozyme-like protein 2,Physical activities,X1080.Time spent using computer,41842,-0.0660142568774106,0.0383878922646541,-0.141254525716133,0.0092260119613114,0.0855114220403509
LYZL2,Lysozyme-like protein 2,Physical activities,X1090.Time spent driving,39616,0.00435423536670958,0.0419113966994681,-0.0777921021642479,0.0865005728976671,0.917256874035338
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1160.Sleep duration,47529,0.00185563653704306,0.0332009330318463,-0.0632181922053758,0.0669294652794619,0.955429047944286
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32357,0.012571423270439,0.0136526507223112,-0.0141877721452909,0.0393306186861689,0.357180564113256
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32357,-0.00186337479092516,0.0122145289803947,-0.0258038515924987,0.0220771020106484,0.878753926286511
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32357,0.00672818997401094,0.0143532135853531,-0.0214041086532812,0.0348604886013031,0.639255237461053
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32357,0.0145095069387159,0.0145632024502902,-0.0140343698638529,0.0430533837412847,0.319128617947212
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32357,0.0166471360131051,0.0148167402661691,-0.0123936749085863,0.0456879469347966,0.261244184403
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32357,-0.00772435113653811,0.0285522933212764,-0.0636868460462398,0.0482381437731636,0.786756929988581
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32357,0.000717743228526017,0.0280598784559407,-0.0542796185451177,0.0557151050021698,0.979593793252331
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32357,-0.0136547156676071,0.0220211249750357,-0.0568161206186771,0.0295066892834629,0.535227282596016
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32357,0.0059024906474224,0.0158485463971707,-0.0251606602910321,0.0369656415858769,0.709581929513304
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32357,0.00493439993937246,0.0109192646653682,-0.0164673588047493,0.0263361586834942,0.65135446298639
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32357,-0.00711825871959535,0.0151402244449502,-0.0367930986316978,0.0225565811925071,0.638256945363483
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32357,0.00106061027262341,0.00929230897814784,-0.0171523153245464,0.0192735358697932,0.909130896209799
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32357,-0.00953655303700745,0.0115723061356431,-0.0322182730628678,0.0131451669888529,0.40991665877635
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32357,-0.0112832137741776,0.0165026152642966,-0.0436283396921989,0.0210619121438437,0.494170284535123
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32357,0.00971628571913468,0.0156011958178621,-0.0208620580838751,0.0402946295221444,0.533439780769559
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32357,-0.0166471924133269,0.0217210444370272,-0.0592204395099003,0.0259260546832464,0.443456180660678
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32357,-0.0204036008667842,0.0206435868493697,-0.0608650310915488,0.0200578293579803,0.32299937917651
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32357,-0.00828091793883245,0.0122932797314253,-0.0323757462124261,0.0158139103347612,0.500576826835887
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32357,0.0134222742462549,0.0114592752744114,-0.00903790529159145,0.0358824537841012,0.241512634617489
LYZL2,Lysozyme-like protein 2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32357,-0.00678796471333464,0.0152275738644176,-0.0366340094875932,0.0230580800609239,0.655777067667935
LYZL2,Lysozyme-like protein 2,Health and medical history,X120040.Fatigue severity over the past week,32363,0.0700480222837999,0.0580336308194241,-0.0436978941222714,0.183793938689871,0.227458753497538
LYZL2,Lysozyme-like protein 2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32361,0.0302864602490214,0.0584035322878037,-0.0841844630350739,0.144757383533117,0.604073467258702
LYZL2,Lysozyme-like protein 2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32360,0.0255920429625297,0.063077655826451,-0.0980401624573141,0.149224248382374,0.684957269271116
LYZL2,Lysozyme-like protein 2,Health and medical history,X120098.Mobility problems today,32366,0.0438972005871773,0.0694441186016242,-0.0922132718720062,0.180007673046361,0.527325000031452
LYZL2,Lysozyme-like protein 2,Health and medical history,X120099.Self-care problems today,32366,0.188229784294426,0.102646588809852,-0.0129575297728841,0.389417098361736,0.0667263402840232
LYZL2,Lysozyme-like protein 2,Health and medical history,X120100.Problems doing usual activities,32366,0.0996997427762716,0.0655964771123454,-0.0288693523639254,0.228268837916469,0.128577387489775
LYZL2,Lysozyme-like protein 2,Health and medical history,X120101.Pain or discomfort today,32366,0.0141740380085004,0.058794346499393,-0.10106288113031,0.129410957147311,0.809500719338247
LYZL2,Lysozyme-like protein 2,Health and medical history,X120102.Anxiety or depression today,32366,0.0256187069578569,0.0685035106598923,-0.108648173935532,0.159885587851246,0.708431780962445
LYZL2,Lysozyme-like protein 2,Health and medical history,X120103.Scale to indicate how health is today,32332,0.000777408251844507,0.00399264452264389,-0.00704817501253751,0.00860299151622653,0.845624916755082
LYZL2,Lysozyme-like protein 2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32342,-0.0130328283981736,0.0714222629501648,-0.153020463780497,0.126954806984149,0.855214101401561
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32320,-0.0886620356741518,0.0725980767361866,-0.230954266077078,0.0536301947287739,0.222019459088272
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32350,0.0322699627017578,0.0576996534210449,-0.0808213580034903,0.145361283407006,0.575990046302746
LYZL2,Lysozyme-like protein 2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32348,0.0277266882355507,0.0596895733211203,-0.089264875473845,0.144718251944946,0.642291792900157
LYZL2,Lysozyme-like protein 2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32352,-0.026856285499215,0.0729196450268,-0.169778789751743,0.116066218753313,0.712659625218158
LYZL2,Lysozyme-like protein 2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32327,0.0224513163469899,0.0743642666506517,-0.123302646288287,0.168205278982267,0.762728640659931
LYZL2,Lysozyme-like protein 2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32349,0.026693632473051,0.0769995842776783,-0.124225552711199,0.177612817657301,0.728846669047902
LYZL2,Lysozyme-like protein 2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32340,-0.0152209669868635,0.113758439033544,-0.238187507492609,0.207745573518882,0.893563530797825
LYZL2,Lysozyme-like protein 2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32307,0.0411046879133545,0.151489019926925,-0.255813791143418,0.338023166970127,0.786138416480623
LYZL2,Lysozyme-like protein 2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",30388,0.0659922888221164,0.0752937006655726,-0.0815833644824059,0.213567942126639,0.38081280705333
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45526,0.0144561818597564,0.0799406526038493,-0.142227497243788,0.171139860963301,0.856497710155346
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43956,-0.032472422756972,0.0519167456495222,-0.134229244230036,0.0692843987160915,0.531669244739864
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1289.Cooked vegetable intake,47072,-0.0555618033203836,0.0345824013213308,-0.123343309910192,0.0122197032694248,0.108145200888107
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46660,-0.0303895075107938,0.0372307330907332,-0.103361744368631,0.0425827293470432,0.414367124152286
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1309.Fresh fruit intake,47120,-0.0463203907667203,0.0356145409414166,-0.116124891011897,0.0234841094784562,0.19340748694365
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1319.Dried fruit intake,45676,-0.0334192803217044,0.0364232568914539,-0.104808863828954,0.0379703031855453,0.358877571570865
LYZL2,Lysozyme-like protein 2,Health and medical history,X134.Number of self-reported cancers,47777,0.468381895638052,0.0513348970017219,0.367765497514677,0.568998293761427,7.80773139286382e-20
LYZL2,Lysozyme-like protein 2,Health and medical history,X135.Number of self-reported non-cancer illnesses,47777,0.0583834899120429,0.0342537329749623,-0.00875382671888311,0.125520806542969,0.0883119226864365
LYZL2,Lysozyme-like protein 2,Health and medical history,"X136.Number of operations, self-reported",47777,0.0856661711130425,0.0347078262199119,0.0176388317220151,0.15369351050407,0.0135862174436112
LYZL2,Lysozyme-like protein 2,Health and medical history,X137.Number of treatments or medications taken,47777,0.049637264570833,0.0336710777307554,-0.0163580477814475,0.115632576923114,0.140446348227639
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1438.Bread intake,46968,0.00228656009231638,0.00266432120597813,-0.00293550947140076,0.00750862965603352,0.39078295882965
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1458.Cereal intake,46591,0.0465159970108535,0.0344744660337963,-0.0210539564153872,0.114085950437094,0.177258150006468
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1488.Tea intake,46983,-0.000932297815440702,0.00247942787609146,-0.00579197645257996,0.00392738082169855,0.706910561339465
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1498.Coffee intake,45933,-0.0244742718950557,0.0345059612958828,-0.0921059560349861,0.0431574122448746,0.478160527163446
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X1528.Water intake,46320,-0.0131309661375959,0.0352242316399405,-0.0821704601518793,0.0559085278766875,0.709314173923658
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1568.Average weekly red wine intake,38685,0.00295866861111088,0.0433177404821223,-0.0819441027338488,0.0878614399560705,0.945546553591407
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,38680,-0.0392558190330602,0.0431108267431384,-0.123753039449611,0.045241401383491,0.362532598801569
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1588.Average weekly beer plus cider intake,38709,-0.0279930126534335,0.0544797924766834,-0.134773405907733,0.078787380600866,0.607383167432108
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1598.Average weekly spirits intake,38645,0.118281897035169,0.0479408166656243,0.0243178963705455,0.212245897699793,0.0136273071464744
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1608.Average weekly fortified wine intake,38709,0.205335548627808,0.0701020442188348,0.0679355419588923,0.342735555296725,0.0034048888130466
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X1737.Childhood sunburn occasions,42212,-0.0118236581573446,0.0409724387701526,-0.0921296381468437,0.0684823218321544,0.772909312661038
LYZL2,Lysozyme-like protein 2,Health and medical history,X1807.Father's age at death,41552,0.00117392461383051,0.00282934122579076,-0.00437158418871937,0.00671943341638039,0.678212309618122
LYZL2,Lysozyme-like protein 2,Health and medical history,X1845.Mother's age,33516,-0.00632509061016343,0.00671634526770954,-0.0194891273348741,0.00683894611454726,0.346347848025812
LYZL2,Lysozyme-like protein 2,Health and medical history,X1873.Number of full brothers,47345,-0.0482376045821482,0.0330035990680373,-0.112924658755501,0.016449449591205,0.143868367442134
LYZL2,Lysozyme-like protein 2,Health and medical history,X1883.Number of full sisters,47347,-0.00712097934982907,0.0330208130578327,-0.0718417729431811,0.057599814243523,0.829261531158706
LYZL2,Lysozyme-like protein 2,Physical measures,X20015.Sitting height,47614,-0.0130876488708111,0.00328594927774199,-0.0195281094551854,-0.00664718828643678,6.82837524354715e-05
LYZL2,Lysozyme-like protein 2,Cognitive function,X20016.Fluid intelligence score,32010,0.00462950707278765,0.0537690046836972,-0.100757742107259,0.110016756252834,0.93138927048886
LYZL2,Lysozyme-like protein 2,Cognitive function,X20018.Prospective memory result,32299,-0.0140673833605451,0.0712672459456227,-0.153751185413966,0.125616418692875,0.843528107956056
LYZL2,Lysozyme-like protein 2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31906,0.000389196456476996,0.00464708758351166,-0.00871909520720586,0.00949748812015986,0.93325696019818
LYZL2,Lysozyme-like protein 2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31891,-0.00188393557617808,0.0046195051069504,-0.0109381655858009,0.00717029443344471,0.683416134459445
LYZL2,Lysozyme-like protein 2,Cognitive function,X20023.Mean time to correctly identify matches,47505,0.00552538586429586,0.00269182053537055,0.000249417614969568,0.0108013541136221,0.0401170609965176
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45067,-0.00233750492241111,0.00552292778284191,-0.0131624433767812,0.00848743353195902,0.672127094534749
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44707,0.0158230694932814,0.0119810754756898,-0.00765983843907055,0.0393059774256334,0.186625714847655
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44677,-0.0120827414215445,0.0165738655866863,-0.0445675179714497,0.0204020351283608,0.465995584562186
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44696,0.0121524369406057,0.0130094877610559,-0.0133461590710638,0.0376510329522753,0.350252573538345
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44701,-0.00244165847767658,0.00983043038539013,-0.0217093020330412,0.0168259850776881,0.803844800013095
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#2.Illnesses of father_Stroke,44834,0.00885500324033766,0.00719844284307939,-0.00525394473209794,0.0229639512127733,0.218663522641341
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44782,-0.00629416599292636,0.00904796451379706,-0.0240281764399686,0.0114398444541159,0.486659494591403
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44702,-0.00368513029844853,0.0115022936977369,-0.0262296259460129,0.0188593653491159,0.748681913943029
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44839,-0.00139645889097006,0.00813280756050764,-0.017336761709565,0.0145438439276249,0.86366969261304
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44884,-0.00260816715275147,0.00615956078637989,-0.0146809062940561,0.00946457198855312,0.67198313639546
LYZL2,Lysozyme-like protein 2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44770,0.00500282868143686,0.00860726620454601,-0.0118674130794733,0.021873070442347,0.561089757680518
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46218,0.00249042032416564,0.00611538575503534,-0.00949573575570363,0.0144765764040349,0.683836855787578
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46109,0.0016659320317452,0.0089541173358033,-0.0158841379464293,0.0192160020099197,0.852405673613185
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46052,-0.0237219517153185,0.0193154571694677,-0.0615802477674752,0.0141363443368382,0.219410400560635
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46080,-0.00559818924522649,0.00960812035121015,-0.0244301051335984,0.0132337266431454,0.560133757042826
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46165,-9.59705643836236e-05,0.00701348755289111,-0.0138424061680502,0.013650465039283,0.989082441550236
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46065,-0.0040917877653643,0.0130147934011939,-0.0296007828317043,0.0214172073009757,0.753223983179935
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46063,0.00192973441146575,0.0115133575561062,-0.0206364463985024,0.0244959152214339,0.866893000941072
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46087,0.00727550994567585,0.00914610065641896,-0.0106508473409053,0.025201867232257,0.426344987738135
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46108,0.0137981240664588,0.0102626759892359,-0.00631672087244353,0.0339129690053611,0.178802217882481
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46249,-0.00364739791987826,0.00530459069356914,-0.0140443956792738,0.00674959983951725,0.491716612942516
LYZL2,Lysozyme-like protein 2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46122,-0.0110448115725885,0.00835364968284986,-0.0274179649509742,0.00532834180579723,0.186130821229285
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43213,-0.0195824695432079,0.00871022442053395,-0.0366545094074544,-0.00251042967896132,0.0245739544740266
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43085,-0.00268871082519907,0.0343715416444715,-0.0700569324483632,0.0646795107979651,0.937649985674275
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43083,0.00702708475501645,0.0355772130828697,-0.0627042528874081,0.076758422397441,0.843425566122345
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43137,-0.00100483995677806,0.00974738929303537,-0.0201097229711274,0.0181000430575713,0.917894146504086
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43096,0.0210875328401941,0.0206795454577035,-0.0194443762569047,0.0616194419372929,0.307870221329016
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43110,0.00147752363596105,0.0146447364920251,-0.0272261598884081,0.0301812071603302,0.919637988923307
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43091,-0.0126610009988359,0.0179979984975003,-0.0479370780539365,0.0226150760562648,0.481773448706033
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43089,0.0162312813428094,0.017677496500683,-0.0184166117985293,0.050879174484148,0.358531853036405
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43104,7.99013415193824e-05,0.0127298763414875,-0.0248706562877962,0.0250304589708349,0.994992035117214
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43112,0.00821697152951644,0.015619171849175,-0.0223966052948666,0.0388305483538995,0.598837203543239
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43263,-0.00454607752849724,0.00643243073391299,-0.0171536417669667,0.00806148670997223,0.479734750137454
LYZL2,Lysozyme-like protein 2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43166,-0.0102588368136005,0.00920332566235273,-0.0282973551118119,0.00777968148461082,0.264998453537756
LYZL2,Lysozyme-like protein 2,Mental health,X20127.Neuroticism score,42773,-0.00223138309700478,0.0349167092754711,-0.0706681332769281,0.0662053670829185,0.949045866438292
LYZL2,Lysozyme-like protein 2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32010,0.054521406007182,0.0541567183611888,-0.0516257619807481,0.160668573995112,0.314094927386875
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20161.Pack years of smoking,30697,-0.00683227037531603,0.00535503124180993,-0.0173281316092635,0.00366359085863144,0.202052442982407
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30697,-0.00737890107604153,0.0052797037170708,-0.0177271203615003,0.00296931820941723,0.162283585244842
LYZL2,Lysozyme-like protein 2,Cognitive function,X20191.Fluid intelligence score,30256,-0.0138650021711405,0.0617844543492062,-0.134962532695585,0.107232528353304,0.822446800608695
LYZL2,Lysozyme-like protein 2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,30256,0.0336376588495324,0.0641771447436803,-0.092149544848081,0.159424862547146,0.60020284842815
LYZL2,Lysozyme-like protein 2,Cognitive function,X20240.Maximum digits remembered correctly,29616,-0.0679213628999157,0.0659827584776487,-0.197247569516107,0.0614048437162759,0.303349208367714
LYZL2,Lysozyme-like protein 2,Physical measures,X20255.Spirometry QC measure,42331,0.014095313719723,0.0456516619991,-0.075381943798513,0.103572571237959,0.757509252875626
LYZL2,Lysozyme-like protein 2,Eye measures,X20261.avMSE,29587,-0.00115982944063188,0.00522516745842463,-0.0114011576591442,0.0090814987778804,0.82434621029067
LYZL2,Lysozyme-like protein 2,Eye measures,X20262.Myopia diagnosis,29587,-0.0247492197247907,0.0819296440700702,-0.185331322102128,0.135832882652547,0.762604125390619
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20280.Glucose-lactate,37448,0.0124362901006103,0.00344531400801656,0.00568347464489785,0.0191891055563228,0.000307793433849183
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37476,0.00964801729030038,0.00328917729942396,0.00320122978342942,0.0160948047971713,0.00336005712629022
LYZL2,Lysozyme-like protein 2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31792,-0.00727353759735181,0.0155829581345279,-0.0378161355410265,0.0232690603463229,0.640683794855934
LYZL2,Lysozyme-like protein 2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31790,0.00941268461743865,0.029397094292607,-0.0482056201960712,0.0670309894309485,0.74883267216852
LYZL2,Lysozyme-like protein 2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31788,-0.0234997370645088,0.037314969154637,-0.0966370766075973,0.0496376024785797,0.52886663679059
LYZL2,Lysozyme-like protein 2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31788,-0.00404464027723152,0.0146617783783381,-0.0327817258987743,0.0246924453443112,0.782661162616645
LYZL2,Lysozyme-like protein 2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31788,-0.0151365114656624,0.028849560566837,-0.0716816501766629,0.0414086272453382,0.599828167521123
LYZL2,Lysozyme-like protein 2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31794,-0.0373665900459502,0.0349619765620687,-0.105892064107605,0.0311588840157044,0.285204869603375
LYZL2,Lysozyme-like protein 2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31794,-0.0193284506478761,0.0235481348285007,-0.0654827949117375,0.0268258936159853,0.411783422299855
LYZL2,Lysozyme-like protein 2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31794,-0.0335565684871965,0.025927226003882,-0.0843739314548052,0.0172607944804122,0.195616375447252
LYZL2,Lysozyme-like protein 2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31794,-0.0149883072555493,0.0418629736640123,-0.0970397356370133,0.0670631211259148,0.720329246453439
LYZL2,Lysozyme-like protein 2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31794,-0.0203686028544078,0.0505609885460313,-0.119468140404629,0.0787309346958135,0.687068724817894
LYZL2,Lysozyme-like protein 2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31794,0.00175740466970768,0.0270345555359843,-0.0512303241808215,0.0547451335202369,0.948171100276104
LYZL2,Lysozyme-like protein 2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31794,-0.0722212789518528,0.051521152276016,-0.173202737412844,0.0287601795091385,0.161023468366109
LYZL2,Lysozyme-like protein 2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31794,-0.0129835846912509,0.035258144575781,-0.0820895480597816,0.0561223786772798,0.712702248629895
LYZL2,Lysozyme-like protein 2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31794,-0.0530477848669829,0.0432283711297769,-0.137775392281346,0.0316798225473799,0.219804789196204
LYZL2,Lysozyme-like protein 2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31794,-0.00179842879534433,0.0197818204783192,-0.04057079693285,0.0369739393421613,0.92756403383813
LYZL2,Lysozyme-like protein 2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31794,0.00173680467722924,0.0324532329470068,-0.0618715318989042,0.0653451412533626,0.957321319063016
LYZL2,Lysozyme-like protein 2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31795,-0.0289404281974414,0.0492840188541271,-0.12553710515153,0.0676562487566477,0.55707583326001
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20600.Liking for adding salt to foods,33122,-0.0523822640118884,0.052513667910957,-0.155309053117364,0.0505445250935873,0.318550847097143
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20601.Liking for aniseed,33122,-0.0311989092444333,0.0522642044139253,-0.133636749895727,0.0712389314068603,0.550559019023996
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20602.Liking for apple juice,33122,0.0698498063033914,0.0520241045921717,-0.0321174386972652,0.171817051304048,0.179422746873976
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20603.Liking for apples,33122,0.0372501720507793,0.0530858199222191,-0.0667980349967701,0.141298379098329,0.482886863954479
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20604.Liking for asparagus,33122,-0.00244733555356788,0.0532646324326708,-0.106846015121603,0.101951344014467,0.963353769591686
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20605.Liking for aubergine,33122,-0.00592104017637199,0.0527121200366167,-0.109236795448141,0.0973947150953968,0.910566047579129
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20606.Liking for avocados,33122,0.12817947247058,0.0535345355249844,0.0232517828416111,0.23310716209955,0.0166717826555138
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20607.Liking for bacon,33122,0.0517413298652557,0.052849067049018,-0.0518428415508195,0.155325501281331,0.327587755299463
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20608.Liking for baked or steamed fish,33122,0.104259461418254,0.0531626985892873,6.05721832509926e-05,0.208458350653257,0.0498947605944406
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20609.Liking for bananas,33122,0.106453319751657,0.0547238592752758,-0.00080544442788387,0.213712083931197,0.051773403252104
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33122,0.0249595717896527,0.0515426092242049,-0.0760639422897889,0.125983085869094,0.628219829504842
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20611.Liking for beef steak,33122,0.0896684518652823,0.0517872861514895,-0.0118346289916371,0.191171532722202,0.0834024808260389
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20612.Liking for beetroot,33122,0.109327407674614,0.0535264792286743,0.0044155083864119,0.214239306962815,0.041132965397806
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20613.Liking for bell pepper,33122,0.0262129755274031,0.0521704940332917,-0.0760411927778486,0.128467143832655,0.615364992024486
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20614.Liking for bicycling,33122,0.03211930940315,0.051898584841908,-0.0696019168869896,0.13384053569329,0.536007715688789
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20615.Liking for biscuits,33122,-0.0214782728018691,0.0518255251014047,-0.123056302000622,0.080099756396884,0.678566371247869
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20616.Liking for bitter foods,33122,-0.0243750580467574,0.0513061718732602,-0.124935154918347,0.0761850388248325,0.634734682840682
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20617.Liking for bitter or ale,33122,-0.00303956447046791,0.0540433366972985,-0.108964504397173,0.102885375456237,0.955149448716692
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20618.Liking for black olives,33122,0.082706113169856,0.0523480630237965,-0.0198960903567852,0.185308316696497,0.114160124240421
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20619.Liking for black pepper,33122,-0.0130667041447496,0.0525934345069602,-0.116149835778392,0.0900164274888924,0.803794122834041
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20620.Liking for blue cheese,33122,-0.000400562518634066,0.0526530503825439,-0.10360054126842,0.102799416231152,0.993930259716495
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20621.Liking for bolognese sauce,33122,0.047127178076949,0.0521220665383433,-0.0550320723382038,0.149286428492102,0.365930726918454
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20622.Liking for broad beans,33122,0.133339218576374,0.0525667234063298,0.0303084406999678,0.236369996452781,0.0112118170576672
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20623.Liking for broccoli,33122,0.0932914562743893,0.054629999923367,-0.0137833435754099,0.200366256124189,0.0877285210047629
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20624.Liking for brown rice,33122,0.0493869459873555,0.0525093551619276,-0.0535313901300226,0.152305282104734,0.346968853676023
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20625.Liking for brussel sprouts,33122,0.0638014985626815,0.0531021280163932,-0.0402786723494491,0.167881669474812,0.229595330112682
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20626.Liking for burgers (meat),33122,0.133029589205527,0.051231593556044,0.0326156658356812,0.233443512575374,0.00943018469002969
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20627.Liking for burn of spicy foods,33122,-0.100108353480566,0.0525305889740243,-0.203068307869653,0.00285160090852206,0.0567202127779023
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20628.Liking for butter on bread,33122,0.0388823519198071,0.0522706191330418,-0.0635680615809548,0.141332765420569,0.456977545884654
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20629.Liking for butternut squash,33122,0.0504609730089746,0.0523925903358944,-0.0522285040493785,0.153150450067328,0.335508243839603
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20630.Liking for cabbage,33122,0.0543575643815174,0.0528646872152942,-0.0492572225604592,0.157972351323494,0.303865853591241
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20631.Liking for cake,33122,-0.0504008847927323,0.0522615052445817,-0.152833435072112,0.0520316654866479,0.334873411076798
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20632.Liking for cake icing,33122,0.000245358857213999,0.0515957005816883,-0.100882214282895,0.101372931997323,0.996205853333856
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20633.Liking for capers,33122,0.000574365716873768,0.0510604024789308,-0.0995040231418306,0.100652754575578,0.991025244177483
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20634.Liking for cauliflower,33122,0.10460319009387,0.0540828766039385,-0.00139924804984996,0.210605628237589,0.0531299634135252
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20635.Liking for cereal or granola bar,33122,-0.0167652601852901,0.0516113816226635,-0.11792356816571,0.0843930477951304,0.74531266939933
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20636.Liking for cheesecake,33122,0.013483231821183,0.0518846472417041,-0.0882106767725569,0.115177140414923,0.794970697653205
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20637.Liking for cherries,33122,0.0811411904166131,0.0572188220679101,-0.0310077008364907,0.193290081669717,0.156201738283746
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20638.Liking for chicken,33122,0.034476812951718,0.0551223476995697,-0.0735629885394386,0.142516614442875,0.531685799574956
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20639.Liking for chilli pepper,33122,-0.0669858243797933,0.0524852871543977,-0.169856987202413,0.0358853384428262,0.201891438909875
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20640.Liking for chips or french fries,33122,0.0651164606057085,0.0520957349662289,-0.0369911799281002,0.167224101139517,0.211355816295793
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20641.Liking for cigarette smoking,33122,0.131218387558261,0.0868253131538965,-0.038959226223376,0.301396001339898,0.130750594111355
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20642.Liking for cod,33122,0.0794566776310565,0.0539774824841975,-0.0263391880379707,0.185252543300084,0.14104808999809
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20643.Liking for coffee with sugar,33122,-0.0312506258268328,0.0591979810185997,-0.147278668623288,0.0847774169696226,0.59758213208394
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20644.Liking for coffee without sugar,33122,-0.0550951539802379,0.0523061080133549,-0.157615125686414,0.0474248177259376,0.292223001566072
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20645.Liking for coriander,33122,-0.0560416655850009,0.0515338316195539,-0.157047975559327,0.0449646443893248,0.276857956872394
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20646.Liking for corn flakes,33122,0.0889339856757039,0.0517400685579017,-0.0124765486977834,0.190344520049191,0.0856754202724462
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20647.Liking for cream,33122,0.00263287798803454,0.0516017493712776,-0.0985065507796697,0.103772306755739,0.959308339883701
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20648.Liking for croissant,33122,0.013076177033447,0.0524138796219833,-0.0896550270256403,0.115807381092534,0.802995981503158
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20649.Liking for cucumber,33122,0.0844317181709659,0.0526984244967477,-0.0188571938426597,0.187720630184591,0.109154978685964
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20650.Liking for curry,33122,-0.0414477432900918,0.0532717659840575,-0.145860404618845,0.062964918038661,0.436564710598925
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20651.Liking for dairy products,33122,0.0352468517330238,0.0529813775161056,-0.0685966481985432,0.139090351664591,0.505896366174765
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20652.Liking for dark chocolate,33122,0.0207352497891598,0.0526036230278445,-0.0823678513454155,0.123838350923735,0.693458505516127
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33122,0.0583855647537676,0.0545342575137033,-0.0485015799730909,0.165272709480626,0.284369352765853
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20654.Liking for dried fruit,33122,0.0686209379217006,0.0522062754744353,-0.0337033620081927,0.170945237851594,0.188739933938693
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20655.Liking for eggs,33122,0.0468692310532702,0.0538327947091561,-0.0586430465766759,0.152381508683216,0.383972376387491
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20656.Liking for exercising alone,33122,-0.000495326743570191,0.05162760641774,-0.101685435322341,0.1006947818352,0.992345256397379
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20657.Liking for exercising with others,33122,0.00323381603657166,0.0512825096659076,-0.0972799029086072,0.103747534981751,0.94972109790406
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33122,0.0478301837712406,0.0528248485749705,-0.0557065194357016,0.151366886978183,0.365252979498842
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20659.Liking for fatty foods,33122,-0.0032716054013368,0.0518555109055704,-0.104908406776255,0.0983651959735811,0.949695660231814
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20660.Liking for fresh tomatoes,33122,0.0112749104144803,0.0582458822151421,-0.102887018727198,0.125436839556159,0.846513701513445
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20661.Liking for fried chicken,33122,0.0528960241120678,0.0516278994775017,-0.0482946588638355,0.154086707087971,0.305598149738985
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20662.Liking for fried or battered fish,33122,0.0431927743945552,0.0517247237377806,-0.0581876841314948,0.144573232920605,0.403712113090139
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20663.Liking for fruit,33122,0.0421517045015083,0.061425910467906,-0.0782430800155875,0.162546489018604,0.492592590573499
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20664.Liking for garlic,33122,0.0487374833134363,0.0526772719974632,-0.0545099698015915,0.151984936428464,0.354883008328356
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20665.Liking for gherkins,33122,-0.0075094012186864,0.0521884337342291,-0.109798731337775,0.0947799289004027,0.885590566699719
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20666.Liking for globe artichoke,33122,0.0402125228958335,0.0516421483060981,-0.0610060877841187,0.141431133575786,0.436191625909866
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20667.Liking for goat's cheese,33122,0.0526755467645323,0.0517570454180023,-0.0487682622547521,0.154119355783817,0.308826917695176
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20668.Liking for going to a cafe,33122,-0.000784070217481857,0.0523770868167906,-0.103443160378391,0.101875019943428,0.988056684039051
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20669.Liking for going to the gym,33122,0.0202987311916897,0.0511559047685562,-0.0799668421546805,0.12056430453806,0.69152374449443
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20670.Liking for going to the pub,33122,0.00856068836796555,0.0521589470831651,-0.093670847915038,0.110792224650969,0.869635044320785
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20671.Liking for grapefruit,33122,-0.0483968295287232,0.051846429851745,-0.150015832038143,0.0532221729806969,0.350605936682311
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20672.Liking for green olives,33122,0.045004487682366,0.0523807168666098,-0.0576617173761892,0.147670692740921,0.390264748355607
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20673.Liking for haddock,33122,0.0317379997934402,0.0537437506772588,-0.073599751533987,0.137075751120867,0.554842024281442
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20674.Liking for ham,33122,0.0451926024367292,0.0517492547115245,-0.0562359367978587,0.146621141671317,0.382524020644055
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20675.Liking for hard cheese,33122,0.0805131702592757,0.0538398191650448,-0.0250128753042121,0.186039215822763,0.134841163225598
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20676.Liking for herring,33122,0.0203782588177327,0.0514482015219754,-0.080460216165339,0.121216733800804,0.692046375284505
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20677.Liking for honey,33122,0.0464578261396285,0.0515404202928202,-0.054561397634299,0.147477049913556,0.36740805429944
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33122,-0.0389276000899358,0.0519266876465378,-0.14070390787715,0.0628487076972782,0.453477088238546
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20679.Liking for ice cream,33122,-0.0656418054016446,0.0528533197927105,-0.169234312195357,0.0379507013920679,0.214284277515367
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20680.Liking for jam,33122,0.0156182991495801,0.0519103081493225,-0.0861259048230921,0.117362503122252,0.763520192407247
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20681.Liking for kiwi fruit,33122,0.166544006807004,0.0518812997330242,0.0648566593302769,0.268231354283732,0.00133174236113822
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20682.Liking for lager,33122,-0.00538817269405654,0.0520418270272309,-0.107390153667429,0.0966138082793161,0.917540432407259
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20683.Liking for lamb,33122,0.0557484638973196,0.0526307980840496,-0.0474079003474178,0.158904828142057,0.289521611848929
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20684.Liking for lemons,33122,-0.0193756841004227,0.0530485936847907,-0.123350927722612,0.0845995595217671,0.714938145238744
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20685.Liking for lentils or beans,33122,0.0124123699790475,0.0534356985421585,-0.0923215991635832,0.117146339121678,0.816321296597581
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20686.Liking for liver,33122,0.155967787492609,0.0524439852627678,0.053177576377584,0.258757998607634,0.00294766666907173
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20687.Liking for mackerel,33122,0.0386661941722907,0.0520819155570531,-0.0634143603195335,0.140746748664115,0.45785840719153
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20688.Liking for marzipan,33122,0.0756877914404529,0.0517692860838717,-0.0257800092839356,0.177155592164841,0.143771694347224
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20689.Liking for mayonnaise,33122,0.162651150938827,0.0524554645099537,0.059838440499318,0.265463861378337,0.00193652651986835
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20690.Liking for melon,33122,0.0590215879887315,0.0551644005848442,-0.0491006371575632,0.167143813135026,0.284684380839058
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20691.Liking for milk chocolate,33122,-0.00263994426796286,0.052534383057692,-0.105607335061039,0.100327446525113,0.959922938172853
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20692.Liking for mushrooms,33122,0.132403247103197,0.0544821190591494,0.0256182937472638,0.23918820045913,0.0151100561099205
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20694.Liking for orange juice,33122,0.0640591204204974,0.0515050238666358,-0.0368907263581088,0.165008967199104,0.213627057922178
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20695.Liking for oranges,33122,-0.0706406094164607,0.0537063679572316,-0.175905090612635,0.0346238717797132,0.188440016649547
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20696.Liking for pasta,33122,0.0413838734890735,0.0528028289253709,-0.0621096712046535,0.144877418182801,0.433212069600139
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20697.Liking for pears,33122,0.0698440255270954,0.0537052706923484,-0.0354183050299074,0.175106356084098,0.193462211903937
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20698.Liking for pizza,33122,-0.0291262798443505,0.052255093612327,-0.131546263324511,0.0732937036358104,0.577277842360501
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20699.Liking for plain yogurt,33122,-0.0120682107948932,0.0518998919431834,-0.113791999003533,0.0896555774137464,0.816132946910029
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20700.Liking for plums,33122,0.0694060330370783,0.0535269824785652,-0.0355068526209094,0.174318918695066,0.194784440686654
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20701.Liking for pollock,33122,-0.0170524581088508,0.0515758043514135,-0.118141034637621,0.0840361184199197,0.740932714043131
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20702.Liking for pork chop,33122,0.0895682082649731,0.0515995579660576,-0.0115669253484998,0.190703341878446,0.0826289562319759
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20703.Liking for porridge,33122,0.0831928832692068,0.0533279824246829,-0.0213299622831718,0.187715728821585,0.11879096432834
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20704.Liking for potato crisps,33122,-0.00902345957378519,0.0519827471592371,-0.11090964400589,0.0928627248583196,0.862195157744384
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20705.Liking for potatoes,33122,0.0437169087899311,0.0526137731453198,-0.0594060865748958,0.146839904154758,0.406051686740781
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20706.Liking for prawns,33122,0.087250401343735,0.0535832597173733,-0.0177727877023166,0.192273590389787,0.103494577560102
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20707.Liking for raw carrots,33122,0.0164468556533219,0.052794450398796,-0.0870302671283183,0.119923978434962,0.755408110097428
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20708.Liking for red meat,33122,0.08699759216229,0.0519719934425333,-0.0148675149850752,0.188862699309655,0.0941800376775868
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20709.Liking for red wine,33122,-0.000853354233927082,0.052617908558188,-0.103984455007976,0.102277746540121,0.987060894579555
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33122,-0.0474155647725719,0.0549196136840028,-0.155058007593217,0.0602268780480736,0.387961799532828
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20711.Liking for roast chicken,33122,0.0643246476571746,0.0551387636486611,-0.0437473290942011,0.17239662440855,0.243405778386765
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20712.Liking for salad dressing,33122,0.19720475904555,0.0520495657361729,0.0951876102026506,0.299221907888448,0.000152409644198821
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20713.Liking for salad leaves,33122,0.04832964078359,0.0541959685362505,-0.0578944575474609,0.154553739114641,0.372547903598409
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20714.Liking for salami,33122,0.015888187050672,0.0519165374630724,-0.0858682263769499,0.117644600478294,0.759586679963942
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20715.Liking for salmon,33122,0.0695785031773338,0.0561920792925161,-0.0405579722359978,0.179714978590665,0.215665771367461
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20716.Liking for salty foods,33122,0.0342182707028957,0.0512802265880268,-0.0662909734096367,0.134727514815428,0.504611062715663
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20717.Liking for salty pretzels,33122,-0.00435928625465868,0.0513096007815224,-0.104926103786443,0.0962075312771252,0.932294805033768
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20718.Liking for sardines,33122,0.0742251951100588,0.0517298913099392,-0.027165391857422,0.17561578207754,0.151362865175781
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20719.Liking for sausages (meat),33122,0.0946735953510054,0.0510914314213506,-0.00546561023484171,0.194812800936852,0.0639130581297347
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20720.Liking for savoury biscuits,33122,0.0915071528757492,0.0526573302659913,-0.0117012144455937,0.194715520197092,0.0822841337795257
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33122,0.0459285586385469,0.0524751872239963,-0.0569228083204859,0.14877992559758,0.38146578179034
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20722.Liking for skimmed milk,33122,0.00203741786205855,0.0521782716314325,-0.100231994535549,0.104306830259666,0.968853619598451
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20723.Liking for smoked fish,33122,-0.00315761118927825,0.0522445594416705,-0.105556947694952,0.099241725316396,0.951807357921191
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20724.Liking for soft cheese,33122,0.0415298481448842,0.052220509416139,-0.0608223503107482,0.143882046600517,0.426473313495939
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20725.Liking for soy sauce,33122,0.011413105492386,0.0521818187884361,-0.0908632593329487,0.113689470317721,0.826874843323644
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20726.Liking for soya milk,33122,0.0790146530157461,0.0519087466924757,-0.0227264905015063,0.180755796532998,0.127999541899891
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20727.Liking for spicy foods,33122,-0.07603116856857,0.0522305002682485,-0.178402949094337,0.0263406119571969,0.145515895598925
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20728.Liking for spinach,33122,0.0243692426693145,0.0532057883753414,-0.0799141025463547,0.128652587884984,0.646950542358741
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20729.Liking for spirits,33122,0.0492348209720192,0.0516121057567522,-0.0519249063112152,0.150394548255253,0.34014094298746
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20730.Liking for strawberries,33122,-0.0332631132475348,0.0585886526145779,-0.148096872372108,0.081570645877038,0.570226339974488
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33122,-0.00886224410427214,0.0542297713606164,-0.11515259597108,0.0974281077625359,0.870191353902375
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20732.Liking for sweet foods,33122,-0.0402194509101016,0.0515263301826544,-0.141211058068104,0.0607721562479011,0.435081988394759
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20733.Liking for taking the stairs,33122,0.0465826874984988,0.0531897374913786,-0.0576691979846033,0.150834572981601,0.381172100320608
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20734.Liking for tea with sugar,33122,-0.0257463953950468,0.0695454239296337,-0.162055426297129,0.110562635507035,0.711235250169848
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20735.Liking for tea without sugar,33122,0.0816050952641094,0.0559810263057132,-0.0281177162950885,0.191327906823307,0.144951858131008
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20736.Liking for tomato ketchup,33122,0.138439525041547,0.0516715944220127,0.0371631999744025,0.239715850108692,0.00739335340387899
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20737.Liking for tinned tuna,33122,0.0671484589427151,0.0524824446262231,-0.0357171325246822,0.170014050410112,0.200774283540189
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20738.Liking for turnip (white),33122,0.0587643073831753,0.0515199057281818,-0.042214707844061,0.159743322610412,0.254062275925704
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20739.Liking for vegetables,33122,0.101884378386463,0.0617497531600514,-0.0191451378072374,0.222913894580164,0.0989881883983537
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20740.Liking for vinegar,33122,-0.0410982458672181,0.0524445323116404,-0.143889529198033,0.0616930374635972,0.433265951572283
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20741.Liking for watching television,33122,0.00606701365141165,0.0531280781598892,-0.0980640195419712,0.110198046844794,0.909085075094858
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20742.Liking for whisky,33122,0.0626426439674019,0.0549547323281697,-0.0450686313958106,0.170353919330614,0.254361423907297
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20743.Liking for white bread,33122,0.0116430937892987,0.0519298890349559,-0.0901394887192148,0.113425676297812,0.82260078895977
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20744.Liking for white rice,33122,0.0495055572395125,0.0517615851031556,-0.0519471495626725,0.150958264041697,0.338889295897558
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20745.Liking for white wine,33122,-0.0170568552777811,0.0518717527891275,-0.118725490744471,0.0846117801889088,0.742294077403726
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33122,0.00388629688097597,0.05234530813185,-0.0987105070574501,0.106483100819402,0.940818378361897
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20747.Liking for whole milk,33122,-0.0164010569222309,0.0517343722543481,-0.117800426540753,0.0849983126962915,0.751232749771403
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20748.Liking for wholemeal bread,33122,0.027059861457293,0.0549592380978302,-0.0806602452144542,0.13477996812904,0.622475666712676
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X20749.Liking for working up a sweat,33122,0.0802754099913385,0.0516536590638993,-0.0209657617739041,0.181516581756581,0.120194986322937
LYZL2,Lysozyme-like protein 2,Physical measures,X21001.Body mass index (BMI),47692,0.0157568888546811,0.00954997079466443,-0.00296105390286119,0.0344748316122234,0.098968507310669
LYZL2,Lysozyme-like protein 2,Physical measures,X21002.Weight,47699,-0.0160326288461737,0.00591480819521438,-0.0276256529087939,-0.00443960478355354,0.00672126024595707
LYZL2,Lysozyme-like protein 2,Physical measures,X21021.Pulse wave Arterial Stiffness index,32211,0.00480098702839333,0.00430370911286849,-0.00363428283282891,0.0132362568896156,0.264650912691654
LYZL2,Lysozyme-like protein 2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32659,0.0746145982329819,0.0544837790229189,-0.0321736086519392,0.181402805117903,0.17088590150733
LYZL2,Lysozyme-like protein 2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32671,0.0139339060342089,0.0567389553485171,-0.0972744464488847,0.125142258517303,0.806014142945392
LYZL2,Lysozyme-like protein 2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32672,0.0146150410809621,0.0565203192199099,-0.0961647845900613,0.125394866751985,0.795965561554362
LYZL2,Lysozyme-like protein 2,Health and medical history,X21040.Satisfaction with bowel habits,32626,-0.0178377813643616,0.0524899008608388,-0.120717987051606,0.0850424243228825,0.733991310313329
LYZL2,Lysozyme-like protein 2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32610,0.0182021321861332,0.054372149981797,-0.088367281778189,0.124771546150455,0.737807659051507
LYZL2,Lysozyme-like protein 2,Health and medical history,X21042.Greatest number of times bowels opened per day,32626,-0.0555625999622667,0.0566973697937862,-0.166689444758088,0.0555642448335543,0.327122285910912
LYZL2,Lysozyme-like protein 2,Health and medical history,X21043.Least number of times bowels opened per week,32544,0.0104779999300501,0.0563468904282212,-0.0999619053092635,0.120917905169364,0.852484518396615
LYZL2,Lysozyme-like protein 2,Health and medical history,X21044.Average number of times bowels opened per day,32597,-0.0212469467455726,0.064732219599585,-0.148122097160759,0.105628203669614,0.74274749316168
LYZL2,Lysozyme-like protein 2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32674,0.113694668703216,0.0574736077714725,0.00104639747112981,0.226342939935302,0.0479387393709012
LYZL2,Lysozyme-like protein 2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32669,0.0373522607419329,0.0574723236648435,-0.0752934936411604,0.149998015125026,0.51576377582755
LYZL2,Lysozyme-like protein 2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32672,0.0206704822714399,0.0673566336356677,-0.111348519654469,0.152689484197349,0.758941600389101
LYZL2,Lysozyme-like protein 2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32671,0.0633502330794759,0.0601740502133541,-0.0545909053386982,0.18129137149765,0.292471289663125
LYZL2,Lysozyme-like protein 2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32668,0.104292460374033,0.0917834829166108,-0.0756031661425244,0.28418808689059,0.255869242232895
LYZL2,Lysozyme-like protein 2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32669,-0.0184211029849112,0.065607216568516,-0.147011247459202,0.11016904148938,0.778887281609946
LYZL2,Lysozyme-like protein 2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32670,-0.00119580333951549,0.16651977473675,-0.327574561823545,0.325182955144515,0.994270495533858
LYZL2,Lysozyme-like protein 2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32674,-0.0528093286472956,0.0617469347057846,-0.173833320670633,0.0682146633760423,0.392435330098488
LYZL2,Lysozyme-like protein 2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32672,0.0100954918418183,0.0653244130988077,-0.117940357831845,0.138131341515481,0.877184666940324
LYZL2,Lysozyme-like protein 2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32447,0.0441908587755241,0.0582959382551452,-0.0700691802045605,0.158450897755609,0.448447272975738
LYZL2,Lysozyme-like protein 2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32670,-0.037254563601611,0.0582942152210002,-0.151511225434771,0.0770020982315495,0.522789858314785
LYZL2,Lysozyme-like protein 2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32671,0.0672181359602975,0.0783848325332671,-0.0864161358049059,0.220852407725501,0.391171478551784
LYZL2,Lysozyme-like protein 2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32674,-0.0393217051399982,0.0567511431091207,-0.150553945633875,0.0719105353538783,0.488404731546442
LYZL2,Lysozyme-like protein 2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32673,-0.0379046061465978,0.0571954397748027,-0.150007668105211,0.0741984558120155,0.507527983517298
LYZL2,Lysozyme-like protein 2,Working and living environment,X21100.Water hardness (USGS classification),47576,0.111205349218998,0.0337072385613757,0.0451391616387021,0.177271536799295,0.00097123441598394
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2139.Age first had sexual intercourse,44455,-0.000402254554372179,0.00302870339539666,-0.00633851320934962,0.00553400410060527,0.894341728796796
LYZL2,Lysozyme-like protein 2,Health and medical history,X2149.Lifetime number of sexual partners,43189,-0.00696209744983151,0.0380208636029069,-0.081482990111529,0.067558795211866,0.854711686786058
LYZL2,Lysozyme-like protein 2,Physical activities,X22032.IPAQ activity group,42432,-0.0636978466342546,0.0381016586633104,-0.138377097614343,0.0109814043458337,0.094583789859971
LYZL2,Lysozyme-like protein 2,Physical activities,X22033.Summed days activity,43018,-0.0048698413065888,0.00286580042078002,-0.0104868101313177,0.000747127518140042,0.0892803021420688
LYZL2,Lysozyme-like protein 2,Physical activities,X22034.Summed minutes activity,42432,-0.00181531105153786,0.00289058940344102,-0.00748086628228227,0.00385024417920655,0.530007178240157
LYZL2,Lysozyme-like protein 2,Physical activities,X22037.MET minutes per week for walking,41541,-0.00278739709291264,0.00295490374250797,-0.00857900842822826,0.00300421424240298,0.345534513683766
LYZL2,Lysozyme-like protein 2,Physical activities,X22038.MET minutes per week for moderate activity,42432,0.000489912899668461,0.00285195039474923,-0.00509990987404003,0.00607973567337695,0.863611082722239
LYZL2,Lysozyme-like protein 2,Physical activities,X22039.MET minutes per week for vigorous activity,42432,-0.0691627006619501,0.0379726815626624,-0.143589156524768,0.00526375520086811,0.0685656516730747
LYZL2,Lysozyme-like protein 2,Physical activities,X22040.Summed MET minutes per week for all activity,41541,-0.00322340469701417,0.00301029977002626,-0.00912359224626565,0.0026767828522373,0.284278119638974
LYZL2,Lysozyme-like protein 2,Eye measures,X2217.Age started wearing glasses or contact lenses,44502,-0.00114620065586764,0.00269798364475179,-0.00643424859958114,0.00414184728784587,0.670960770480506
LYZL2,Lysozyme-like protein 2,Working and living environment,X22501.Year ended full time education,30075,-0.000729452174123053,0.0127858486096276,-0.0257897154489932,0.0243308111007471,0.954506177246185
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X22506.Tobacco smoking,30044,0.0921873749999341,0.143303720783206,-0.18868791773515,0.373062667735018,0.52005543027526
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46195,0.0364889080079779,0.0758733612597309,-0.112222880061095,0.185200696077051,0.630579217043931
LYZL2,Lysozyme-like protein 2,Physical measures,X23098.Weight,47338,-0.0154782387973089,0.00596477180964834,-0.0271691915442196,-0.00378728605039811,0.00946671439265686
LYZL2,Lysozyme-like protein 2,Physical measures,X23099.Body fat percentage,47339,0.0180855797969914,0.00611763296345827,0.00609501918861322,0.0300761404053696,0.00311668153137563
LYZL2,Lysozyme-like protein 2,Physical measures,X23100.Whole body fat mass,47333,0.00551069345339335,0.00586848267866938,-0.00599153259679863,0.0170129195035853,0.347724189950385
LYZL2,Lysozyme-like protein 2,Physical measures,X23101.Whole body fat-free mass,47338,-0.0204377923693091,0.00489099031994473,-0.0300241333964007,-0.0108514513422174,2.94317672795158e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23102.Whole body water mass,47338,-0.0209471833725649,0.00490797535294044,-0.0305668150643282,-0.0113275516808016,1.98036437348356e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23104.Body mass index (BMI),47338,0.0195642053011882,0.00967913687042963,0.000593097035146088,0.0385353135672302,0.0432628385341232
LYZL2,Lysozyme-like protein 2,Physical measures,X23105.Basal metabolic rate,47336,-0.021646445735638,0.00533294781240089,-0.0320990234479437,-0.0111938680233322,4.94466169491592e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23106.Impedance of whole body,47332,0.0149228087395991,0.0040033983586743,0.0070761479565975,0.0227694695226007,0.000193827135908412
LYZL2,Lysozyme-like protein 2,Physical measures,X23107.Impedance of leg (right),47335,0.0145146594251211,0.00328552225682629,0.00807503580174154,0.0209542830485006,1.00185135723704e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23108.Impedance of leg (left),47334,0.0131976397950567,0.00324378041177869,0.00683983018797045,0.0195554494021429,4.74553384949924e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23109.Impedance of arm (right),47327,0.00673305328047947,0.00401961291494492,-0.00114538803281258,0.0146114945937715,0.0939380578266523
LYZL2,Lysozyme-like protein 2,Physical measures,X23110.Impedance of arm (left),47333,0.00861168454127697,0.00402599690590152,0.000720730605709994,0.0165026384768439,0.0324446692446942
LYZL2,Lysozyme-like protein 2,Physical measures,X23111.Leg fat percentage (right),47334,0.0374669577456478,0.00965196518333372,0.0185491059863137,0.0563848095049819,0.00010397885005558
LYZL2,Lysozyme-like protein 2,Physical measures,X23112.Leg fat mass (right),47333,0.00834472385330519,0.0111104556163496,-0.0134317691547401,0.0301212168613505,0.452618580984241
LYZL2,Lysozyme-like protein 2,Physical measures,X23113.Leg fat-free mass (right),47333,-0.024008191024065,0.00497789412713973,-0.0337648635132589,-0.0142515185348712,1.4235161828986e-06
LYZL2,Lysozyme-like protein 2,Physical measures,X23114.Leg predicted mass (right),47332,-0.0242950370231727,0.0049971919242597,-0.0340895331947217,-0.0145005408516237,1.17131169663474e-06
LYZL2,Lysozyme-like protein 2,Physical measures,X23115.Leg fat percentage (left),47329,0.0328124826900739,0.00993407552890326,0.0133416946534236,0.0522832707267243,0.000957951499324879
LYZL2,Lysozyme-like protein 2,Physical measures,X23116.Leg fat mass (left),47329,0.00364254277227068,0.011126192910277,-0.0181647953318722,0.0254498808764136,0.743380106373794
LYZL2,Lysozyme-like protein 2,Physical measures,X23117.Leg fat-free mass (left),47327,-0.0220850776915185,0.00510038800208422,-0.0320818381756036,-0.0120883172074334,1.49690201245485e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23118.Leg predicted mass (left),47326,-0.0219768704716989,0.00512047324897822,-0.0320129980396962,-0.0119407429037016,1.77830120443425e-05
LYZL2,Lysozyme-like protein 2,Physical measures,X23119.Arm fat percentage (right),47326,0.0103163735701077,0.00681663919750406,-0.00304423925700029,0.0236769863972156,0.130189226891155
LYZL2,Lysozyme-like protein 2,Physical measures,X23120.Arm fat mass (right),47324,-0.000803491918383112,0.00613209871258954,-0.0128224053950586,0.0112154215582924,0.895752337726562
LYZL2,Lysozyme-like protein 2,Physical measures,X23121.Arm fat-free mass (right),47325,-0.0141011906842854,0.0047710878383787,-0.0234525228475076,-0.00474985852106313,0.00312429959584554
LYZL2,Lysozyme-like protein 2,Physical measures,X23122.Arm predicted mass (right),47324,-0.0148847532968347,0.00476433004221228,-0.0242228401795708,-0.00554666641409867,0.00178507724056229
LYZL2,Lysozyme-like protein 2,Physical measures,X23123.Arm fat percentage (left),47322,0.0165091383548969,0.00764494818063331,0.00152503992085561,0.0314932367889382,0.0308230486101227
LYZL2,Lysozyme-like protein 2,Physical measures,X23124.Arm fat mass (left),47322,0.00420079286664623,0.00629595203096764,-0.00813927311405035,0.0165408588473428,0.504637563260628
LYZL2,Lysozyme-like protein 2,Physical measures,X23125.Arm fat-free mass (left),47322,-0.0149726214189639,0.00513897484805159,-0.0250450121211451,-0.00490023071678282,0.00357699212968026
LYZL2,Lysozyme-like protein 2,Physical measures,X23126.Arm predicted mass (left),47320,-0.0150804446851717,0.00515058752600151,-0.0251755962361347,-0.00498529313420878,0.00341587750018396
LYZL2,Lysozyme-like protein 2,Physical measures,X23127.Trunk fat percentage,47319,0.00879183251962929,0.00386543309834471,0.00121558364687365,0.0163680813923849,0.0229466382310133
LYZL2,Lysozyme-like protein 2,Physical measures,X23128.Trunk fat mass,47315,0.00325366321327613,0.00446008143422751,-0.00548809639780979,0.0119954228243621,0.465698706304166
LYZL2,Lysozyme-like protein 2,Physical measures,X23129.Trunk fat-free mass,47310,-0.0165767019159403,0.00457085387840758,-0.0255355755176191,-0.0076178283142614,0.000287791563580711
LYZL2,Lysozyme-like protein 2,Physical measures,X23130.Trunk predicted mass,47307,-0.0161463582247272,0.00458101053238994,-0.0251251388682115,-0.00716757758124295,0.000424906712856135
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23400.Total Cholesterol,37482,0.0123468718672532,0.00341253442526649,0.00565830439373091,0.0190354393407755,0.000297902874593038
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37482,0.0132236994440547,0.00329624730832543,0.00676305471973684,0.0196843441683725,6.06085684030202e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37482,0.0134605166256434,0.00329106686006653,0.00701002557991301,0.0199110076713738,4.33935986892471e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23403.VLDL Cholesterol,37482,0.0176049273458871,0.00322389291205913,0.0112860972382512,0.023923757453523,4.8277196637795e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37482,0.0100293753754256,0.00329908668385148,0.00356316547507673,0.0164955852757745,0.00237011434179205
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23405.LDL Cholesterol,37482,0.0125633598425562,0.00329765159448203,0.00609996271737143,0.019026756967741,0.000139723876455719
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23406.HDL Cholesterol,37482,-0.000727362533340075,0.0038257298244404,-0.00822579298924327,0.00677106792256312,0.849215032774502
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23407.Total Triglycerides,37482,0.025295873074474,0.00348222642498421,0.0184707092815049,0.032121036867443,3.96344594849883e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23408.Triglycerides in VLDL,37482,0.025244859630497,0.00348532554517979,0.0184136215619447,0.0320760976990494,4.62889533045168e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23409.Triglycerides in LDL,37482,0.0236795531322668,0.00347113930984236,0.0168761200849758,0.0304829861795578,9.3852373752181e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23410.Triglycerides in HDL,37482,0.0180041131880348,0.0032805185954525,0.0115742967409479,0.0244339296351217,4.13660592273181e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37482,0.0170526104466678,0.00347749818302809,0.0102367140079327,0.0238685068854029,9.51819607331579e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23412.Phospholipids in VLDL,37482,0.021591717373549,0.00331970986661361,0.0150850860349863,0.0280983487121116,8.10152783225086e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23413.Phospholipids in LDL,37482,0.0122360228357469,0.00327344251279965,0.0058200755106596,0.0186519701608342,0.000186306936756717
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23414.Phospholipids in HDL,37482,0.00545918492743676,0.00370067246281084,-0.00179413309967249,0.012712502954546,0.140186363320485
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23415.Total Esterified Cholesterol,37482,0.0117411755854799,0.00342471638323941,0.00502873147433062,0.0184536196966291,0.000609108329502104
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37482,0.0154911156813428,0.00320401930720287,0.0092112378392252,0.0217709935234604,1.3473311058649e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37482,0.0141612976413686,0.00329014220492741,0.0077126189197109,0.0206099763630263,1.68844702498987e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37482,-0.00160702982754624,0.00379992736587781,-0.00905488746466676,0.00584082780957427,0.672367416925672
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23419.Total Free Cholesterol,37482,0.0135879579322624,0.00338033312540203,0.00696250500647445,0.0202134108580504,5.85978266232748e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37482,0.0202713301937413,0.00328138642507412,0.013839812800596,0.0267028475868866,6.69902517015016e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23421.Free Cholesterol in LDL,37482,0.00780852902407647,0.00332608973223439,0.00128939314889707,0.0143276648992559,0.0189066154114983
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23422.Free Cholesterol in HDL,37482,0.00226496656805295,0.00383884087607006,-0.00525916154904437,0.00978909468515026,0.555192069799046
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37482,0.0193222664971174,0.00339536552036125,0.0126673500772094,0.0259771829170255,1.29187400915672e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23424.Total Lipids in VLDL,37482,0.0233203867972646,0.00338623181414696,0.0166833724415366,0.0299574011529927,5.96685124056885e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23425.Total Lipids in LDL,37482,0.0135259091630484,0.00329076295553534,0.0070760137701991,0.0199758045558977,3.97625255041206e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23426.Total Lipids in HDL,37482,0.00429924039253248,0.00374884132647788,-0.00304848860736417,0.0116469693924291,0.25147772107339
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37482,0.0120870065930287,0.00350175210953669,0.00522357245833679,0.0189504407277206,0.000558828875372149
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23428.Concentration of VLDL Particles,37482,0.019750965591983,0.0032699742826049,0.0133418159980774,0.0261601151858887,1.58215437750941e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23429.Concentration of LDL Particles,37482,0.013609414764481,0.00326278665278029,0.00721435292503159,0.0200044766039303,3.05094136615824e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23430.Concentration of HDL Particles,37482,0.0101458147157272,0.00350880331581615,0.00326856021672759,0.0170230692147269,0.00384003246518418
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37482,0.0247079015873748,0.0036788924836934,0.0174972723193357,0.0319185308554139,1.94364819455757e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37482,-0.00374433425339633,0.00335967754743616,-0.0103293022463712,0.00284063373957854,0.265088666329304
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37482,-0.0108765531794405,0.00399577040175383,-0.018708263166878,-0.003044843192003,0.00649711495378036
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23434.Phosphoglycerides,37470,0.0168747775211341,0.00349613001662881,0.0100223626885416,0.0237271923537265,1.40388776544296e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37470,0.0217492084855023,0.0036988608136169,0.0144994412908132,0.0289989756801914,4.20390936402946e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23436.Total Cholines,37470,0.0157606353723783,0.0035067150265567,0.00888747392032715,0.0226337968244294,7.03629900791434e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23437.Phosphatidylcholines,37470,0.0151186699919217,0.00350884612044044,0.0082413315958584,0.0219960083879849,1.6539977020231e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23438.Sphingomyelins,37469,0.0108626275869498,0.00352626261441165,0.00395115286270299,0.0177741023111967,0.00207089065146368
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23439.Apolipoprotein B,37482,0.0135526305001577,0.00326187258807528,0.0071593602275302,0.0199459007727853,3.27561134411882e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23440.Apolipoprotein A1,37482,0.00717256051259236,0.00362961640505804,5.85123586786095e-05,0.0142866086665061,0.0481621548445982
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37482,0.00814229329956467,0.00329496344306822,0.00168416495115096,0.0146004216479784,0.0134812597974959
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23442.Total Fatty Acids,37470,0.0249613917958651,0.00349371213137468,0.0181137160183708,0.0318090675733595,9.50189135087321e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23443.Degree of Unsaturation,37470,-0.0137070224176116,0.00365072473462055,-0.0208624428974678,-0.00655160193775528,0.000174371976285339
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37470,0.00932714936584768,0.00341268563909575,0.00263828551322001,0.0160160132184754,0.00628294422798488
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37470,0.0187175504660239,0.00338496636730796,0.0120830163861003,0.0253520845459475,3.27123675789337e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37470,0.0184417956005181,0.00341633817794498,0.011745772771746,0.0251378184292903,6.85247099840502e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37470,0.0278074991910022,0.00357852266680176,0.0207935947640707,0.0348214036179336,8.39127380570792e-15
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23448.Saturated Fatty Acids,37470,0.0249473832637496,0.00356542098720403,0.0179591581288297,0.0319356083986695,2.74225389160126e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23449.Linoleic Acid,37470,0.0177100487008292,0.00335114115685972,0.0111418120333842,0.0242782853682743,1.27886694265772e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23450.Docosahexaenoic Acid,37470,0.00213817551474892,0.0035896791685228,-0.00489759565555578,0.00917394668505361,0.551422564330186
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37470,-0.00259217326649904,0.00340004294461684,-0.00925625743794803,0.00407191090494996,0.445838536851697
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37470,-0.0204276958484733,0.0038193106347741,-0.0279135446926305,-0.012941847004316,9.01717308683709e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37470,-0.0225537807060353,0.0038262701776966,-0.0300532702543206,-0.0150542911577499,3.85225993130337e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37470,0.0240235467439152,0.0037729887880851,0.0166284887192684,0.031418604768562,1.9891718394661e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37470,0.00888821193138137,0.00356265488690491,0.00190540835304774,0.015871015509715,0.0126141059381083
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37470,-0.00740917158547459,0.00367348859778098,-0.0146092092371253,-0.000209133933823867,0.0437232447031854
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37470,-0.0135249636350447,0.00362576154049879,-0.0206314562544223,-0.00641847101566708,0.000192109251144242
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37470,-0.0247004316708095,0.00381054466272247,-0.0321690992097455,-0.0172317641318734,9.37003525197504e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37468,-0.00239170240836144,0.00338817033897646,-0.00903251627275531,0.00424911145603243,0.480264252434695
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23460.Alanine,37476,0.0101227802340781,0.00327407355187052,0.00370559607241188,0.0165399643957443,0.00199367133509482
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23461.Glutamine,37440,-0.0178498825171279,0.0033119703977342,-0.024341344496687,-0.0113584205375689,7.18860425476002e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23462.Glycine,37465,0.000767743222739706,0.00313954404749725,-0.00538576311035491,0.00692124955583432,0.806816698846319
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23463.Histidine,37465,-0.00226096140533356,0.00321520411763267,-0.00856276147589359,0.00404083866522648,0.48193791098045
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37473,0.00689434405188001,0.00328639413119277,0.000453011554742192,0.0133356765490178,0.0359381029510609
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23465.Isoleucine,37479,0.00292360918362151,0.00322565368473329,-0.00339867203845573,0.00924589040569876,0.364761164468018
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23466.Leucine,37480,0.00531121185867136,0.00328505892473859,-0.00112750363381627,0.011749927351159,0.105950364589462
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23467.Valine,37473,0.00834008555588217,0.00331647851278506,0.00183978767082345,0.0148403834409409,0.0119239239616797
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23468.Phenylalanine,37479,-0.000227584483970057,0.00320853119927138,-0.00651630563454196,0.00606113666660185,0.943453720827718
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23469.Tyrosine,37465,0.00186022563912811,0.00324841814875648,-0.00450667393243459,0.00822712521069082,0.566887633575386
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23470.Glucose,37458,-0.00486783182830683,0.00342818552418881,-0.0115870754557169,0.00185141179910324,0.155647922816823
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23471.Lactate,37455,0.0279658961145832,0.00321559745064707,0.0216633251113149,0.0342684671178514,3.81493225849255e-18
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23472.Pyruvate,37442,0.0124377032319287,0.00329932692916284,0.00597102245076955,0.0189043840130879,0.000164121723000264
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23473.Citrate,37481,0.00138897403243511,0.00328252943429017,-0.00504478365877361,0.00782273172364384,0.672199097449029
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23474.3-Hydroxybutyrate,37322,0.00465740710044748,0.00309277241885925,-0.00140442684051665,0.0107192410414116,0.132117295768091
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23475.Acetate,37473,-0.00990489644099589,0.00332452826217743,-0.0164209718348637,-0.00338882104712813,0.0028940399610733
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23476.Acetoacetate,37482,-0.00396173813251384,0.00320186960631084,-0.0102374025608831,0.0023139262958554,0.215990506552794
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23477.Acetone,37482,-0.00293167740299497,0.00321746922193516,-0.00923791707798789,0.00337456227199796,0.36222004903234
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23478.Creatinine,37098,0.00696842943849586,0.00381953549897657,-0.000517860139498209,0.0144547190164899,0.0681124819890357
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23479.Albumin,37480,0.00693045445801437,0.00331732758856602,0.000428492384424967,0.0134324165316038,0.0367119620143406
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23480.Glycoprotein Acetyls,37482,0.0269494828291924,0.00352913681938622,0.0200323746631954,0.0338665909951894,2.39141240558254e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37482,0.0221629472549769,0.00352360165844187,0.0152566880044308,0.029069206505523,3.27919217024509e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37482,0.0222932158027764,0.0035237422735274,0.0153866809466627,0.0291997506588901,2.5886509664127e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37482,0.0217862678556973,0.00347617647208314,0.0149729619704143,0.0285995737409802,3.78921621446425e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37482,0.022886455537362,0.00346116572324068,0.0161025707198102,0.0296703403549137,3.93005163158577e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37482,0.0233682793809357,0.00343604754197748,0.0166336261986598,0.0301029325632116,1.08489616934446e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37482,0.023278199766951,0.00348249750797304,0.0164525046513238,0.0301038948825782,2.41411789777479e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37482,0.0210664926610754,0.00355341886303164,0.0141017916895334,0.0280311936326174,3.1342432822798e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37482,0.0235238496920788,0.00345293506680461,0.0167560969611418,0.0302916024230158,9.99839019391253e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37482,0.0232545886047824,0.00346012024300648,0.0164727529284897,0.0300364242810751,1.88319745284984e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37482,0.0224506051395197,0.00343853094136866,0.0157110844944371,0.0291901257846023,6.86070902780502e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37482,0.0212243258657725,0.00333939629669437,0.0146791091242516,0.0277695426072935,2.14340372117907e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37482,0.0194679095903693,0.00326991291859427,0.0130588802699245,0.025876938910814,2.68978328528651e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37482,0.0224490578698798,0.00341198517725569,0.0157615669224586,0.0291365488173009,4.90174208121834e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37482,0.0235526498637377,0.00350066847585546,0.016691339651061,0.0304139600764144,1.79145828890715e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37482,0.0235978700066415,0.0034232926189249,0.0168882164735487,0.0303075235397343,5.70128460674138e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37482,0.023133538282226,0.00341549330227943,0.0164391714097583,0.0298279051546936,1.31445831633272e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37482,0.0225232466491981,0.00339906457661584,0.0158610800790311,0.0291854132193652,3.57723769447961e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37482,0.0211159135677499,0.00330440939953458,0.0146392711446621,0.0275925559908377,1.71282609935343e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37482,0.0190493603165395,0.00322634268304523,0.0127257286577708,0.0253729919753081,3.62921318974727e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37482,0.0228600845899093,0.00338718306919505,0.016221205774287,0.0294989634055316,1.5517103051211e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37482,0.023570282182991,0.00346665875696295,0.0167756310193436,0.0303649333466384,1.09835972342278e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37482,0.0185971997146925,0.00325099866065988,0.0122252423397991,0.0249691570895859,1.08573571582925e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37482,0.0204914470525057,0.0032846900448648,0.0140534545645707,0.0269294395404407,4.55540239198511e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37482,0.017859234146448,0.00324311459342288,0.0115027295433392,0.0242157387495569,3.72303278177765e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37482,0.0114218198896794,0.00326791121251613,0.0050167139131478,0.017826925866211,0.000475381264966828
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37482,0.00761147966549193,0.00332348552447169,0.00109744803752741,0.0141255112934564,0.0220250497809108
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37482,0.0157723185003106,0.00323533897546728,0.00943105410839472,0.0221135828922264,1.10084172703255e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37482,0.0244867098191065,0.0034020002356292,0.0178187893572732,0.0311546302809397,6.45724997640825e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37482,0.0210013511585898,0.00327084634594001,0.0145904923205474,0.0274122099966322,1.40290862657292e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37482,0.0210815066051431,0.00325225179077601,0.0147070930952221,0.027455920115064,9.3697334764058e-11
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37482,0.0183004038570574,0.00321576029483284,0.011997513679185,0.0246032940349298,1.29133295408181e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37482,0.0161756379643411,0.00317807460630794,0.00994661173597751,0.0224046641927046,3.63511886816924e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37482,0.0163950116427795,0.00315864082162787,0.0102040756323889,0.0225859476531701,2.12852597312592e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37482,0.0154122844742012,0.0032227818927855,0.00909563196434162,0.0217289369840608,1.75204587200584e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37482,0.0231664570372718,0.003367810035132,0.016565549368413,0.0297673647061305,6.31194961984229e-12
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37482,0.0135901329861157,0.0032917073783499,0.0071383865245499,0.0200418794476815,3.67257304045002e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37482,0.0136768982607961,0.00328933128269005,0.00722980894672364,0.0201239875748686,3.23161454649861e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37482,0.0139846571698249,0.00328236878084017,0.0075512143593782,0.0204180999802717,2.0536768207013e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37482,0.00855059026587086,0.00334933329365413,0.00198589701030876,0.015115283521433,0.0106936037050142
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37482,0.006862635302983,0.00337534388825026,0.000246961282012499,0.0134783093239535,0.0420559555667107
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37482,0.0120839587880164,0.00329763524927132,0.00562059369944462,0.0185473238765882,0.000248872163012648
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37482,0.0201073189882911,0.00334537221576764,0.0135503894453865,0.0266642485311957,1.89906897735496e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23523.Concentration of IDL Particles,37482,0.00767191571180037,0.00331167410119244,0.00118103447346318,0.0141627969501376,0.0205394557461812
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23524.Total Lipids in IDL,37482,0.00816463122907521,0.0034031443012406,0.00149446839864363,0.0148347940595068,0.0164474363546895
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23525.Phospholipids in IDL,37482,0.00844090951189801,0.00341049283256804,0.00175634356006465,0.0151254754637314,0.01333690241913
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23526.Cholesterol in IDL,37482,0.00594110373422136,0.00340956001174494,-0.000741633888798716,0.0126238413572414,0.0814473827381185
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37482,0.00601751902087201,0.0034039840572775,-0.000654289731391895,0.0126893277731359,0.0771199054737755
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23528.Free Cholesterol in IDL,37482,0.00551887262802733,0.00342044441159472,-0.00118519841869832,0.012222943674753,0.106661054596536
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23529.Triglycerides in IDL,37482,0.0195745000118402,0.00339422810603792,0.0129218129240059,0.0262271870996746,8.25287164450609e-09
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37482,0.0126686492123113,0.00328070394191668,0.00623846948615459,0.019098828938468,0.000113207994328211
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23531.Total Lipids in Large LDL,37482,0.0121310892325062,0.00331808022927394,0.00562765198312928,0.0186345264818831,0.000257132465472007
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23532.Phospholipids in Large LDL,37482,0.0106914991133428,0.00330170093925586,0.00422016527240134,0.0171628329542843,0.0012059637746863
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23533.Cholesterol in Large LDL,37482,0.0112039566571655,0.00332847556985262,0.00468014454025439,0.0177277687740767,0.000764614422603152
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37482,0.012526892228568,0.00331437083500748,0.00603072539195336,0.0190230590651827,0.000157800620726844
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37482,0.00730255857149578,0.00336317109091645,0.000710743233299525,0.013894373909692,0.0299241246684392
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23536.Triglycerides in Large LDL,37482,0.0219407101258223,0.00344421246440001,0.0151900536955983,0.0286913665560464,1.94985981949312e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37482,0.0142791482687645,0.00325066479355908,0.0079078452733887,0.0206504512641403,1.12842804169784e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37482,0.0157416696730238,0.00326732926084956,0.00933770432175864,0.0221456350242889,1.46710317578707e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37482,0.0149182025401218,0.00324417609516157,0.00855961739360515,0.0212767876866385,4.2963817958163e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37482,0.0147670667418915,0.00326723920278384,0.00836327790443513,0.0211708555793478,6.24613241112776e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37482,0.0165092919854411,0.0032780012252338,0.0100844095839829,0.0229341743868994,4.80739001001265e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37482,0.00944389479435154,0.00327077987461056,0.00303316624011484,0.0158546233485882,0.00389137579012331
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37482,0.0253925600340668,0.00349406459789217,0.0185441934221982,0.0322409266459355,3.87508196422736e-13
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37482,0.0143601238921664,0.00324252062908223,0.0080047834591652,0.0207154643251675,9.55786525274179e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23545.Total Lipids in Small LDL,37482,0.0146765833989809,0.00327555184746282,0.00825650177795379,0.0210966650200081,7.50518259545926e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23546.Phospholipids in Small LDL,37482,0.0115580467877389,0.0032630823108862,0.00516240545840194,0.0179536881170758,0.000398396092622315
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23547.Cholesterol in Small LDL,37482,0.0137670956444632,0.00326511698719498,0.00736746634956102,0.0201667249393654,2.49889724312923e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37482,0.0163555048260987,0.00328506496818193,0.00991677748846214,0.0227942321637353,6.48160787977753e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37482,0.00639406479240766,0.0032487952103662,2.64261800899078e-05,0.0127617034047254,0.0490737746115701
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23550.Triglycerides in Small LDL,37482,0.026877172072981,0.00351936852045437,0.0199792097728905,0.0337751343730716,2.37945416509629e-14
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37482,-0.0073410838225335,0.00379362920712398,-0.0147765970684965,9.44294234295024e-05,0.0529986055136381
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37482,-0.0110797916091656,0.00381428918751919,-0.0185557984167033,-0.00360378480162803,0.00368091972060003
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37482,-0.011822882911408,0.00381262349292369,-0.0192956249575385,-0.0043501408652776,0.00193290644155165
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37482,-0.0121918122805773,0.00379334756085949,-0.0196267734998619,-0.00475685106129271,0.00131219220150882
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37482,-0.011767197290354,0.00385733986183934,-0.0193275834195591,-0.00420681116114889,0.00228844379248243
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37482,-0.0124889397787615,0.00352466549351113,-0.0193972841460433,-0.00558059541147966,0.000396538549267179
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37482,0.0170050688301465,0.0034078920718289,0.0103256003693619,0.0236845372909312,6.1187386543099e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37482,-0.00707719137277436,0.00403036637596389,-0.0149767094696636,0.000822326724114855,0.0791174923376484
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23559.Total Lipids in Large HDL,37482,-0.00738616761316462,0.00400825106749791,-0.0152423397054605,0.000470004479131289,0.0653895721559831
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23560.Phospholipids in Large HDL,37482,-0.00633657690146638,0.0039557506322916,-0.0140898481407579,0.00141669433782515,0.10920979472675
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23561.Cholesterol in Large HDL,37482,-0.00997664257281463,0.0040099452945991,-0.0178361353502289,-0.0021171497954004,0.0128596866988802
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37482,-0.010437737502875,0.00399900939476183,-0.0182757959166082,-0.00259967908914179,0.00906244018504095
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37482,-0.00833787447343343,0.00400186027272554,-0.0161815206079755,-0.000494228338891378,0.0372251457331488
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23564.Triglycerides in Large HDL,37482,0.0111072006338165,0.00336412365169681,0.00451351827649076,0.0177008829911423,0.000963721844572293
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37482,0.00635213743707843,0.0035979217600878,-0.000699789212693668,0.0134040640868505,0.077502881018168
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37482,0.00766610081196189,0.00356454818325732,0.000679586372777537,0.0146526152511463,0.0315220552665685
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37482,0.00909908333795717,0.00353947324864548,0.00216171577061204,0.0160364509053023,0.0101589988697186
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37482,0.00323646232222112,0.00361389833938051,-0.00384677842296468,0.0103197030674069,0.370504420780337
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37482,0.00263307776011858,0.00359510665804108,-0.00441333128964193,0.00967948680987909,0.463933959019723
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37482,0.00554202637359417,0.00366066903456998,-0.00163288493416299,0.0127169376813513,0.130065790896198
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37482,0.0170381247658723,0.00325112522788801,0.0106659193192118,0.0234103302125328,1.62478648480756e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37482,0.0159340334868279,0.00321832910701485,0.00962610843707883,0.022241958536577,7.474701208628e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23573.Total Lipids in Small HDL,37482,0.0182373032950933,0.00325243026290016,0.011862539979809,0.0246120666103776,2.09703569040248e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23574.Phospholipids in Small HDL,37482,0.0179045240699549,0.00328714677991351,0.0114617163813244,0.0243473317585853,5.22064175129357e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23575.Cholesterol in Small HDL,37482,0.0141229021320315,0.00322666999305495,0.00779862894564379,0.0204471753184192,1.21300888931778e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37482,0.012060367451158,0.00318857248219231,0.00581076538606107,0.0183099695162549,0.000156035407188572
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37482,0.0183308418124716,0.00335268030955846,0.011759588405737,0.0249020952192062,4.64784959570818e-08
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23578.Triglycerides in Small HDL,37482,0.0214693482061782,0.00335748550029437,0.0148886766256012,0.0280500197867551,1.66601402605246e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,0.00479659914394495,0.00308018944996393,-0.00124057217798435,0.0108337704658742,0.1194388401576
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,-0.00376033709515897,0.00322192047012759,-0.010075301216609,0.0025546270262911,0.24318836783897
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,-0.000228682847797777,0.00314435052727795,-0.00639160988126256,0.00593424418566701,0.942023615976532
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,-0.00661345051388146,0.00327721621426091,-0.0130367942938328,-0.00019010673393007,0.0436120143062299
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36763,-0.000784786306143607,0.0031194456603133,-0.00689889980035767,0.00532932718807046,0.801370868240746
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,37282,0.00473318865493155,0.00301254420936257,-0.00117139799541909,0.0106377753052822,0.116170171342177
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,37282,-0.0136293111151669,0.00342881420973217,-0.020349786966242,-0.00690883526409189,7.07843392830552e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,37282,-0.0141096633164825,0.00343810517863109,-0.0208483494665995,-0.00737097716636561,4.08743351154181e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,37282,-0.00847354733676726,0.0032435287976302,-0.0148308637801224,-0.00211623089341208,0.00900013893202269
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,37282,0.00937104066909312,0.00329049216209168,0.00292167603139342,0.0158204053067928,0.00440766676099516
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37477,0.0141673701383601,0.00322167820859751,0.00785288084950897,0.0204818594272112,1.10366944790058e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37477,-0.0062177955407995,0.00316684808071646,-0.0124248177790038,-1.0773302595247e-05,0.0496207362591183
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37477,-0.0109379919156178,0.00332139449671565,-0.0174479251291804,-0.00442805870205507,0.000993205871649117
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37477,0.0038121069668952,0.00304502852623321,-0.00215614894452188,0.00978036287831229,0.210624506332808
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37477,-0.00165512596665471,0.00298905417456039,-0.00751367214879308,0.00420342021548365,0.579773833298102
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37482,-0.00643228511301537,0.00334846812818543,-0.0129952826442588,0.000130712418228083,0.0547581017998397
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37482,-0.0151883227547302,0.00350100305734589,-0.0220502887471281,-0.0083263567623322,1.44684556311006e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37482,-0.0164928433776376,0.00352991706413325,-0.0234114808233387,-0.00957420593193639,3.00820867782796e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37482,-0.0111971939935165,0.00342004012110631,-0.0179004726308848,-0.00449391535614811,0.00106314975568117
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37482,0.0134248594392677,0.00347464030601047,0.00661456443948722,0.0202351544390483,0.000112237711861866
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37482,-0.0100540088405277,0.00341519253619496,-0.0167477862114698,-0.0033602314695856,0.00324669499418677
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37482,-0.00817747060730638,0.00332814231824069,-0.0147006295510581,-0.00165431166355463,0.0140205711560546
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37482,-0.00576554494600355,0.00323527485889751,-0.0121066836694427,0.00057559377743556,0.0747581402116229
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37482,-0.0106218785695881,0.0034247238461678,-0.017334337308077,-0.00390941983109924,0.0019293552432292
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37482,0.0088626515729783,0.00335846230491806,0.00228006545533891,0.0154452376906177,0.00832740685383386
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37482,0.00604385157554585,0.00342655314904421,-0.000672192596580799,0.0127598957476725,0.0777843141794233
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37482,-0.0131362832975308,0.00355123651724599,-0.020096706871333,-0.0061758597237287,0.000217277902830143
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37482,-0.0137672163206552,0.00357620431397666,-0.0207765767760495,-0.00675785586526098,0.0001188408871503
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37482,-0.0064109944850413,0.00345736497085806,-0.0131874298279231,0.000365440857840492,0.0637187228324863
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37482,0.0138913406105522,0.00354159916438861,0.00694980624835048,0.0208328749727538,8.81444420884709e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37482,0.000101638701620865,0.00321423567815704,-0.00619826322756692,0.00640154063080865,0.974774444251759
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37482,-0.0082122660105819,0.00339785138403977,-0.0148720547232998,-0.00155247729786395,0.0156669741255439
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37482,-0.00731540432729302,0.00339512236604728,-0.0139698441647457,-0.000660964489840349,0.0312051043384944
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37482,-0.00912728494310836,0.00345932281613443,-0.0159075576627318,-0.00234701222348487,0.00833825409747936
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37482,0.0112826056285369,0.00350008724576988,0.00442243462682796,0.0181427766302459,0.0012693660815224
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37482,-0.0117741216025568,0.00320502036513712,-0.0180559615182256,-0.0054922816868881,0.000240068476432215
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37482,-0.00419101004207457,0.0035189928898885,-0.011088236106256,0.00270621602210688,0.233687605859251
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37482,0.0104864888448871,0.00323991525333235,0.00413625494835568,0.0168367227414185,0.00121241619870169
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37482,-0.0179836307034098,0.00349698029384212,-0.0248377120793403,-0.0111295493274793,2.74867268263992e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37482,0.00867624951670899,0.00348691130422821,0.0018419033604217,0.0155105956729963,0.0128503375747572
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37482,-0.00842181379398835,0.00316011260834369,-0.014615634506342,-0.00222799308163472,0.00770749504142887
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37482,-0.00307718754400071,0.00324963793809951,-0.00944647790267576,0.00329210281467434,0.343690772436279
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37482,0.0142048225813593,0.00329722864898785,0.00774225442934313,0.0206673907333755,1.65862341146705e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37482,-0.021839973412977,0.0035665502400736,-0.0288304118835212,-0.0148495349424327,9.41403109959879e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37482,0.00791213031936654,0.00336365346553808,0.0013193695269119,0.0145048911118212,0.0186753744655712
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37482,-0.0165657376241417,0.00322111502855765,-0.0228791230801147,-0.0102523521681687,2.74515456671447e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37482,0.00300686150619286,0.0032595056216635,-0.0033817695122676,0.00939549252465332,0.356290098230114
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37482,0.0168118846909267,0.00325124579756914,0.0104394429276912,0.0231843264541622,2.3641427238636e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37482,-0.0179390782159148,0.00348435096878822,-0.0247684061147397,-0.0111097503170899,2.66445119716934e-07
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37482,0.0159035859076711,0.00344041633759566,0.00916036988598363,0.0226468019293586,3.82643208562821e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37480,-0.013586566192793,0.00370740460788824,-0.0208530792242539,-0.00632005316133205,0.000248601137288409
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37480,0.000423775889618562,0.0037015085910692,-0.00683118094887708,0.0076787327281142,0.908853242247059
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37480,-0.000155056801924661,0.00371458389089704,-0.00743564122808286,0.00712552762423354,0.966704444815183
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37480,0.0032696877122146,0.00395525792480745,-0.004482617820408,0.0110219932448372,0.408440037093605
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37480,0.0234822615378958,0.00369328641848844,0.0162434201576585,0.0307211029181332,2.11089838137551e-10
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37482,0.00941324450481204,0.00384618815134092,0.00187471572818384,0.0169517732814403,0.0144013436834354
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37482,-0.0145598735705848,0.00383458264106798,-0.0220756555470781,-0.0070440915940916,0.000147127813468889
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37482,-0.0146010992147767,0.00386901567741894,-0.0221843699425178,-0.00701782848703557,0.000161457576082081
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37482,-0.0084091962394831,0.00371890272067586,-0.0156982455720078,-0.00112014690695841,0.0237630689318716
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37482,0.0172432702434742,0.00372684321507706,0.00993865754192316,0.0245478829450252,3.7497986782124e-06
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37482,0.0078987827633497,0.00363441670536922,0.000775326020826035,0.0150222395058734,0.0297735245190914
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37482,-0.0127092659778804,0.00354645194098502,-0.019660311782211,-0.00575822017354971,0.000340054134155224
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37482,-0.0138344286270945,0.00351788262378655,-0.0207294785697162,-0.00693937868447288,8.44668911047923e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37482,-0.00231411990572017,0.00383050224518798,-0.00982190430628861,0.00519366449484828,0.545767979188016
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37482,0.0148328308981364,0.00344893668379797,0.00807291499789234,0.0215927467983804,1.71501383311736e-05
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37482,-0.00143776830716126,0.0033535399864459,-0.00801070668059522,0.0051351700662727,0.668125704381468
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37482,-0.00914351504445362,0.00336571205354699,-0.0157403106694057,-0.00254671941950152,0.00660301912595221
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37482,-0.00902217274300047,0.00337387099378186,-0.0156349598908129,-0.00240938559518802,0.00750166575678204
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37482,-0.000559330308428422,0.00345546737697339,-0.00733204636729626,0.00621338575043942,0.871412149573489
LYZL2,Lysozyme-like protein 2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37482,0.0162738057939134,0.00344643951518921,0.00951878434414253,0.0230288272436842,2.36065475174446e-06
LYZL2,Lysozyme-like protein 2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47429,-0.00257485801586206,0.00279725445130075,-0.00805747674041153,0.00290776070868741,0.357323943091067
LYZL2,Lysozyme-like protein 2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47429,-0.00265549844583303,0.0027410725690365,-0.00802800068114458,0.00271700378947852,0.332664770922698
LYZL2,Lysozyme-like protein 2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45782,-0.00168648945404854,0.00264023286395171,-0.00686134586739389,0.0034883669592968,0.522982405744848
LYZL2,Lysozyme-like protein 2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45782,-0.00158230213915515,0.00288473538881075,-0.00723638350122422,0.00407177922291391,0.583348473758379
LYZL2,Lysozyme-like protein 2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45782,-0.000623232865691517,0.00281946528585827,-0.00614938482597372,0.00490291909459068,0.825058361090296
LYZL2,Lysozyme-like protein 2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45782,-0.000788332452031348,0.0025916305771259,-0.0058679283831981,0.00429126347913541,0.760990711521483
LYZL2,Lysozyme-like protein 2,Working and living environment,X24009.Traffic intensity on the nearest road,47429,0.0261652098499874,0.0732688188061278,-0.117441675010023,0.169772094709998,0.721010879099846
LYZL2,Lysozyme-like protein 2,Working and living environment,X24010.Inverse distance to the nearest road,47429,-0.00395174052755422,0.00245641444769307,-0.00876631284503263,0.000862831789924199,0.107686200480964
LYZL2,Lysozyme-like protein 2,Working and living environment,X24011.Traffic intensity on the nearest major road,47429,0.00143181975911385,0.00245903472849077,-0.00338788830872805,0.00625152782695575,0.560391197819209
LYZL2,Lysozyme-like protein 2,Working and living environment,X24012.Inverse distance to the nearest major road,47429,0.000352979720494671,0.00250272975095114,-0.00455237059136957,0.00525833003235891,0.887841246885777
LYZL2,Lysozyme-like protein 2,Working and living environment,X24013.Total traffic load on major roads,47429,0.0198128316843577,0.0512227959864346,-0.0805838484490542,0.12020951181777,0.698909966864629
LYZL2,Lysozyme-like protein 2,Working and living environment,X24015.Sum of road length of major roads within 100m,47429,0.00997931815076003,0.0498543386970941,-0.0877351856955444,0.107693821997064,0.8413497898985
LYZL2,Lysozyme-like protein 2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47429,-0.00441531893774366,0.00278783065182806,-0.00987946701532666,0.00104882913983934,0.113256859962376
LYZL2,Lysozyme-like protein 2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47429,-0.00503443446288287,0.00278230380334233,-0.0104877499174338,0.000418880991668097,0.0703944711043923
LYZL2,Lysozyme-like protein 2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47429,-0.00381935308664153,0.0027579207829722,-0.00922487782126704,0.00158617164798398,0.166106629103885
LYZL2,Lysozyme-like protein 2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47374,-0.00093447911328224,0.00271102606779684,-0.00624809020616404,0.00437913197959956,0.730326289958647
LYZL2,Lysozyme-like protein 2,Working and living environment,X24020.Average daytime sound level of noise pollution,47429,-0.000970740030624122,0.00247181112733203,-0.0058154898401949,0.00387400977894666,0.694526843000926
LYZL2,Lysozyme-like protein 2,Working and living environment,X24021.Average evening sound level of noise pollution,47429,-0.000982408527545402,0.00247181919550717,-0.00582717415073945,0.00386235709564865,0.691044118525887
LYZL2,Lysozyme-like protein 2,Working and living environment,X24022.Average night-time sound level of noise pollution,47429,-0.000981234806502301,0.00247177435747386,-0.00582591254715107,0.00386344293414646,0.691388932650534
LYZL2,Lysozyme-like protein 2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47429,-0.000965211944425207,0.00247178846611384,-0.00580991733800833,0.00387949344915791,0.696176891565554
LYZL2,Lysozyme-like protein 2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47429,-0.000949281797137194,0.00247187070403827,-0.00579414837705221,0.00389558478277782,0.700956980328565
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44816,0.00454042314514372,0.00285858975393111,-0.00106241277256125,0.0101432590628487,0.112224156209998
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44816,-0.00262984828060775,0.00260483254549549,-0.00773532006977891,0.00247562350856341,0.31269724624762
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24502.Water percentage, buffer 1000m",44816,0.0011220670182136,0.00255299039389581,-0.00388179415382219,0.0061259281902494,0.660296074391806
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44816,0.00374294969147418,0.0026942465400161,-0.00153777352695737,0.00902367290990573,0.164775578358456
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44816,-0.00238468207202959,0.00263039442405232,-0.00754025514317215,0.00277089099911297,0.364635828540526
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24505.Water percentage, buffer 300m",44816,0.000793278371888733,0.00257633158427184,-0.00425633153328407,0.00584288827706153,0.758153931853003
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47576,0.00290652070687259,0.00273168364611242,-0.00244757923950776,0.00826062065325294,0.287338266463189
LYZL2,Lysozyme-like protein 2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47576,0.00271479296614119,0.00258000612383672,-0.00234201903657879,0.00777160496886117,0.292699145334763
LYZL2,Lysozyme-like protein 2,Working and living environment,X24508.Distance (Euclidean) to coast,47576,-0.000421519787450903,0.00245419091727547,-0.00523173398531083,0.00438869441040902,0.863631574893709
LYZL2,Lysozyme-like protein 2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,33885,-0.0496385434932449,0.0566370014522025,-0.160647066339562,0.061369979353072,0.380816943952121
LYZL2,Lysozyme-like protein 2,Health and medical history,X2704.Years since last cervical smear test,42153,-0.00897527838366307,0.040239778218769,-0.0878452436924502,0.0698946869251241,0.823503114483515
LYZL2,Lysozyme-like protein 2,Health and medical history,X2714.Age when periods started (menarche),47009,0.0455072057860069,0.0338339774374484,-0.020807389991392,0.111821801563406,0.178633926591823
LYZL2,Lysozyme-like protein 2,Health and medical history,X2734.Number of live births,47715,-0.0718325809149682,0.0321702790752373,-0.134886327902433,-0.00877883392750306,0.0255659101480658
LYZL2,Lysozyme-like protein 2,Health and medical history,X2744.Birth weight of first child,42920,-0.0795246113637277,0.0362507792900801,-0.150576138772285,-0.00847308395517064,0.028266873109019
LYZL2,Lysozyme-like protein 2,Health and medical history,X2754.Age at first live birth,40184,-0.000461484347816048,0.00313951021759287,-0.00661492437429807,0.00569195567866597,0.883139850824219
LYZL2,Lysozyme-like protein 2,Health and medical history,X2764.Age at last live birth,40137,-0.000859227236295235,0.00302169403466465,-0.00678174754423794,0.00506329307164747,0.77614376096609
LYZL2,Lysozyme-like protein 2,Health and medical history,X2794.Age started oral contraceptive pill,42253,-0.00333025794684942,0.00337979548533877,-0.00995465709811341,0.00329414120441456,0.324468992056236
LYZL2,Lysozyme-like protein 2,Health and medical history,X2804.Age when last used oral contraceptive pill,40591,-0.00239376254183967,0.00295480119720979,-0.00818517288837087,0.00339764780469153,0.417879460750115
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2867.Age started smoking in former smokers,29189,0.00594666871249833,0.00568553626376616,-0.00519698236448334,0.01709031978948,0.295647063011138
LYZL2,Lysozyme-like protein 2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",33584,0.0252119547557405,0.0605425019575474,-0.0934513490810524,0.143875258592533,0.677102260652464
LYZL2,Lysozyme-like protein 2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,33576,0.0355026175208177,0.065562247439381,-0.0929993874603691,0.164004622502005,0.588169280157219
LYZL2,Lysozyme-like protein 2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,33604,0.0924983054711578,0.0706327169360839,-0.0459418197235666,0.230938430665882,0.190375093780516
LYZL2,Lysozyme-like protein 2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",33563,0.0639861376438664,0.0679006663954162,-0.0690991684911494,0.197071443778882,0.346038885285135
LYZL2,Lysozyme-like protein 2,Mental health,X28739.Difficulty with standing for long periods,33619,-0.0238141445923608,0.0614114340343681,-0.144180555299722,0.0965522661150006,0.698187628530767
LYZL2,Lysozyme-like protein 2,Mental health,X28740.Difficulty with taking care of household responsibilities,33643,-0.028136015756765,0.0668381528293047,-0.159138795302202,0.102866763788672,0.673796027631147
LYZL2,Lysozyme-like protein 2,Mental health,X28741.Difficulty learning a new task,33547,-0.016385973942429,0.0734314761815894,-0.160311667258344,0.127539719373486,0.82342653317929
LYZL2,Lysozyme-like protein 2,Mental health,X28742.Difficulty with joining in community activities,33312,0.0776373356146101,0.0766840133744758,-0.0726633305993624,0.227938001828583,0.311359284520992
LYZL2,Lysozyme-like protein 2,Mental health,X28743.Difficulty with being emotionally affected by health problems,33583,0.0389078241463377,0.064180886912312,-0.0868867142017939,0.164702362494469,0.544382849708925
LYZL2,Lysozyme-like protein 2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,33634,0.0547778599005179,0.0937195869345048,-0.128912530491112,0.238468250292147,0.558907219579551
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29166,-0.00306060776189218,0.0743814732309029,-0.148848295294462,0.142727079770678,0.967180091940341
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2897.Age stopped smoking,29197,-0.00536458777337144,0.00586288220687439,-0.0168558368988452,0.00612666135210236,0.360233588933995
LYZL2,Lysozyme-like protein 2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,32683,-0.0133277438646937,0.00815169752142583,-0.0293050710066884,0.00264958327730091,0.102094528040474
LYZL2,Lysozyme-like protein 2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,32683,0.0124117093037179,0.00868791311383046,-0.00461660039938982,0.0294400190068256,0.153151994506904
LYZL2,Lysozyme-like protein 2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,32683,0.0134671505008403,0.028984001708926,-0.0433414928486547,0.0702757938503352,0.642200980538384
LYZL2,Lysozyme-like protein 2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,32683,0.0186376133864425,0.030972120070073,-0.0420677419509005,0.0793429687237855,0.547354123543689
LYZL2,Lysozyme-like protein 2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,32683,0.00467538497213322,0.0321869894879674,-0.0584111144242829,0.0677618843685494,0.884511534013791
LYZL2,Lysozyme-like protein 2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,32683,0.0298605886341,0.0262422997711592,-0.0215743189173722,0.0812954961855721,0.255203704787083
LYZL2,Lysozyme-like protein 2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,32683,0.00537743469485625,0.0122959357834779,-0.0187225994407605,0.029477468830473,0.661880384141146
LYZL2,Lysozyme-like protein 2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,32683,0.0473422027972263,0.0213556792147349,0.00548507153634597,0.0891993340581066,0.0266610005784205
LYZL2,Lysozyme-like protein 2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32626,0.0746987749222702,0.0722560110801122,-0.0669230067947497,0.21632055663929,0.301256959087961
LYZL2,Lysozyme-like protein 2,Mental health,X29003.Recent feelings of depression,32613,0.0101846128862384,0.0696897720805809,-0.1264073403917,0.146776566164177,0.883812785780418
LYZL2,Lysozyme-like protein 2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32631,-0.0109532777353295,0.057446181086077,-0.12354779266404,0.101641237193381,0.848788681185022
LYZL2,Lysozyme-like protein 2,Mental health,X29005.Recent feelings of tiredness or low energy,32639,0.0486034957723282,0.0590415109059164,-0.0671178656032678,0.164324857147924,0.410413206278035
LYZL2,Lysozyme-like protein 2,Mental health,X29006.Recent poor appetite or overeating,32646,0.0547417693829285,0.0748077055323211,-0.091881333460421,0.201364872226278,0.464332060110007
LYZL2,Lysozyme-like protein 2,Mental health,X29007.Recent feelings of inadequacy,32603,-0.0322603425759571,0.0764844637538053,-0.182169891533416,0.117649206381501,0.673189807487291
LYZL2,Lysozyme-like protein 2,Mental health,X29008.Recent trouble concentrating on things,32645,-0.0489327690812607,0.0780847111740578,-0.201978802982414,0.104113264819893,0.530897880800161
LYZL2,Lysozyme-like protein 2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32633,-0.0416671130541393,0.140243722866984,-0.316544809873428,0.233210583765149,0.766393882421443
LYZL2,Lysozyme-like protein 2,Mental health,X29010.Recent thoughts of suicide or self-harm,32578,-0.0763637650888796,0.156300621661298,-0.382712983545025,0.229985453367265,0.625159478217312
LYZL2,Lysozyme-like protein 2,Mental health,X29038#0.Substances taken for depression_None of options listed,31793,0.024172300166883,0.0160421595117848,-0.00727033247621525,0.0556149328099813,0.131905370063964
LYZL2,Lysozyme-like protein 2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31793,-0.0301552854194139,0.0319671362913417,-0.0928108725504437,0.0325003017116159,0.345547549940039
LYZL2,Lysozyme-like protein 2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31793,-0.00584897214557426,0.0150100566777567,-0.0352686832339775,0.023570738942829,0.696791721418346
LYZL2,Lysozyme-like protein 2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31793,-0.0135465125776412,0.0441578792809397,-0.100095955968283,0.0730029308130007,0.759023698495576
LYZL2,Lysozyme-like protein 2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31793,0.00438765783517178,0.0276623850335586,-0.049830616830603,0.0586059325009466,0.87397689692045
LYZL2,Lysozyme-like protein 2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31793,0.00388086300672279,0.0288635623368024,-0.0526917191734099,0.0604534451868554,0.893046129861141
LYZL2,Lysozyme-like protein 2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31793,0.0268425986751913,0.0344550577026948,-0.0406893144220905,0.094374511772473,0.43596877570481
LYZL2,Lysozyme-like protein 2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31793,0.0146764866872894,0.0380097741421101,-0.0598226706312464,0.0891756440058252,0.69941601315189
LYZL2,Lysozyme-like protein 2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31793,-0.0362108137405778,0.0288881262981053,-0.0928315412848641,0.0204099138037085,0.210069416156068
LYZL2,Lysozyme-like protein 2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31793,0.0181869491169961,0.0160917085527318,-0.0133527996463582,0.0497266978803503,0.258426264146423
LYZL2,Lysozyme-like protein 2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31793,-0.00666143765878525,0.0245390548639803,-0.0547579851921867,0.0414351098746162,0.786042830677291
LYZL2,Lysozyme-like protein 2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31793,0.0111323647107687,0.0378602208086062,-0.0630736680740996,0.0853383974956369,0.76873675345544
LYZL2,Lysozyme-like protein 2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31793,0.0822928787388595,0.0496584471074916,-0.015037677591824,0.179623435069543,0.0975262541742123
LYZL2,Lysozyme-like protein 2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31793,0.0271720610676787,0.0333907715722433,-0.0382738512139181,0.0926179733492755,0.415809074300536
LYZL2,Lysozyme-like protein 2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31793,0.0495222372499069,0.0547454653683364,-0.0577788748720324,0.156823349371846,0.365711964420777
LYZL2,Lysozyme-like protein 2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31793,0.0664599248312868,0.0510101134309616,-0.0335198974933979,0.166439747155972,0.192657481417042
LYZL2,Lysozyme-like protein 2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31793,-0.00924465290000295,0.0278394526273273,-0.0638099800495645,0.0453206742495586,0.73984572391133
LYZL2,Lysozyme-like protein 2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31793,-0.00818357740583273,0.0272430189553645,-0.0615798945583471,0.0452127397466817,0.763886882473626
LYZL2,Lysozyme-like protein 2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31793,0.115005147170802,0.0374797572302833,0.041544822999447,0.188465471342157,0.00215949460067542
LYZL2,Lysozyme-like protein 2,Mental health,X29058.Recent feelings or nervousness or anxiety,32511,0.0193188487650181,0.0648755877106454,-0.107837303147847,0.146475000677883,0.765876449020001
LYZL2,Lysozyme-like protein 2,Mental health,X29059.Recent inability to stop or control worrying,32521,0.0101395291641668,0.0672587548045337,-0.121687630252719,0.141966688581053,0.88017351003404
LYZL2,Lysozyme-like protein 2,Mental health,X29060.Recent worrying too much about different things,32514,0.0503961028102841,0.0625477912811052,-0.0721975681006821,0.17298977372125,0.42042719527385
LYZL2,Lysozyme-like protein 2,Mental health,X29061.Recent trouble relaxing,32522,-0.0170774532323974,0.066780812741411,-0.147967846205563,0.113812939740768,0.798170519451068
LYZL2,Lysozyme-like protein 2,Mental health,X29062.Recent restlessness,32529,0.0373961324661483,0.0952211198654831,-0.149237262470198,0.224029527402495,0.694529726365424
LYZL2,Lysozyme-like protein 2,Mental health,X29063.Recent easy annoyance or irritability,32498,0.0137192986774987,0.069496508595631,-0.122493858169938,0.149932455524935,0.843511772319471
LYZL2,Lysozyme-like protein 2,Mental health,X29064.Recent feelings of foreboding,32490,0.0523997602468908,0.0743323237507742,-0.0932915943046267,0.198091114798408,0.480868576241563
LYZL2,Lysozyme-like protein 2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31793,-0.0051730755616306,0.0160990763750983,-0.0367272652568233,0.0263811141335621,0.747971385286768
LYZL2,Lysozyme-like protein 2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31793,0.0370406026953409,0.0272180497370942,-0.0163067747893636,0.0903879801800454,0.173592192499672
LYZL2,Lysozyme-like protein 2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31793,-0.0422559526123472,0.0348265979779228,-0.110516084649076,0.0260041794243816,0.225044948690706
LYZL2,Lysozyme-like protein 2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31793,0.0404466917003507,0.0390609217222467,-0.0361127148752529,0.117006098275954,0.300480242654323
LYZL2,Lysozyme-like protein 2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31793,-0.0226266588856151,0.0263182922215682,-0.0742105116398888,0.0289571938686586,0.389965265675262
LYZL2,Lysozyme-like protein 2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31793,0.0154724122663284,0.0261024170246803,-0.0356883251020451,0.0666331496347018,0.553361486815878
LYZL2,Lysozyme-like protein 2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31793,0.0157160581510291,0.0266877637241748,-0.0365919587483535,0.0680240750504116,0.555955675026066
LYZL2,Lysozyme-like protein 2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31793,-0.0124927479290947,0.0242375646592065,-0.0599983746611395,0.0350128788029501,0.606268671231607
LYZL2,Lysozyme-like protein 2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31793,0.0156245083568742,0.0323494190926423,-0.0477803530647048,0.0790293697784532,0.629115869637076
LYZL2,Lysozyme-like protein 2,Mental health,X29076.Felt loved as a child,32493,0.029233658880351,0.0618496431255082,-0.091991641645645,0.150458959406347,0.636470833245566
LYZL2,Lysozyme-like protein 2,Mental health,X29077.Physically abused by family as a child,32507,-0.156669484748272,0.0895630603300686,-0.332213082995207,0.0188741134986621,0.0802834014655559
LYZL2,Lysozyme-like protein 2,Mental health,X29078.Felt hated by family member as a child,32487,-0.0470122887021099,0.0814402372397828,-0.206635153692084,0.112610576287864,0.563779202659736
LYZL2,Lysozyme-like protein 2,Mental health,X29079.Sexually molested as a child,32405,-0.080716903247588,0.103539515350495,-0.283654353334558,0.122220546839382,0.435663795644964
LYZL2,Lysozyme-like protein 2,Mental health,X29080.Someone to take to doctor when needed as a child,32471,0.00305968628394409,0.0863050183854936,-0.166098149751623,0.172217522319512,0.971720196341277
LYZL2,Lysozyme-like protein 2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32485,0.0264733536514104,0.106233093624487,-0.181743509852583,0.234690217155404,0.803211965681639
LYZL2,Lysozyme-like protein 2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32422,-0.0532904362549543,0.0813015425355988,-0.212641459624728,0.106060587114819,0.512186379511764
LYZL2,Lysozyme-like protein 2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32487,-0.0995926182760404,0.0912640429722456,-0.278470142501642,0.079284905949561,0.275192092277649
LYZL2,Lysozyme-like protein 2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32450,-0.0818321626182329,0.113410706098417,-0.30411714657113,0.140452821334664,0.470588664048465
LYZL2,Lysozyme-like protein 2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32456,-0.099129737238393,0.114060694129837,-0.322688697732874,0.124429223256088,0.384820475362185
LYZL2,Lysozyme-like protein 2,Mental health,X29086.Experienced a violent or sexual assault,32486,0.0301837218977742,0.102006979622012,-0.16974995816137,0.230117401956918,0.76731517298392
LYZL2,Lysozyme-like protein 2,Mental health,X29087.Experienced a life-threatening injury or illness,32497,0.232561464688329,0.0715344920108584,0.0923538603470463,0.372769069029611,0.00115457192981721
LYZL2,Lysozyme-like protein 2,Mental health,X29088.Experienced a marital separation or divorce,32499,0.0841317758359808,0.0654638167084197,-0.0441773049125218,0.212440856584483,0.198771784546874
LYZL2,Lysozyme-like protein 2,Mental health,X29089.Experienced the death of a spouse or partner,32506,-0.0729951587598564,0.0850802083163003,-0.239752367059805,0.0937620495400923,0.390941751073179
LYZL2,Lysozyme-like protein 2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32495,-0.123354900973667,0.0862099025206952,-0.29232630991423,0.0456165079668956,0.152507203393519
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29091.Frequency of drinking alcohol,32503,-0.0131681540134277,0.055264557379688,-0.121486686477616,0.0951503784507609,0.811673994153077
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31451,0.0227578392511591,0.0692188212278322,-0.112911050355392,0.15842672885771,0.742331000691542
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31463,-0.0516388608113666,0.0705377544162893,-0.189892859467294,0.0866151378445603,0.464147841571217
LYZL2,Lysozyme-like protein 2,Mental health,X29104.Ever used cannabis,32497,-0.0293806215038968,0.0847180779303664,-0.195428054247415,0.136666811239621,0.728747174048309
LYZL2,Lysozyme-like protein 2,Mental health,X29108.Ever thought that life not worth living,32454,-0.0517279143941767,0.0673623411201184,-0.183758102989609,0.0803022742012553,0.442565972433814
LYZL2,Lysozyme-like protein 2,Mental health,X29109.Ever contemplated self-harm,32480,0.0350562191799976,0.0877785478736824,-0.13698973465242,0.207102173012415,0.689630377022067
LYZL2,Lysozyme-like protein 2,Mental health,X29111.Ever self-harmed,32495,0.0181697608311536,0.136156527104837,-0.248697032294326,0.285036553956634,0.893842747106585
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32487,0.0947634673172081,0.0913331223691926,-0.0842494525264094,0.273776387160826,0.299506823021755
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,32369,0.0438013027457662,0.0340181237012254,-0.0228742197086357,0.110476825200168,0.197927312684527
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,32369,0.0363927180260399,0.0272071086120877,-0.016933214853652,0.0897186509057319,0.181059419296129
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,32369,0.035247732622324,0.027523860816768,-0.0186990345785413,0.0891944998231893,0.200363078468774
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,32369,0.0339839907482143,0.0353391364994432,-0.0352807167906944,0.103248698287123,0.336253249538902
LYZL2,Lysozyme-like protein 2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32481,-0.0856831664354814,0.0621614804109436,-0.207519668040931,0.0361533351699681,0.168119317190125
LYZL2,Lysozyme-like protein 2,Health and medical history,X29153.Pain or discomfort today,32493,-0.00696038854352667,0.0594361133879923,-0.123455170783991,0.109534393696938,0.90677814034725
LYZL2,Lysozyme-like protein 2,Mental health,X29154.Anxiety or depression today,32493,0.132754738165261,0.0690561151422953,-0.00259524751363785,0.26810472384416,0.0545884480974256
LYZL2,Lysozyme-like protein 2,Mental health,X29166.Frequency of confiding in someone close,32291,0.00290122883507199,0.0561034932153413,-0.107061617866997,0.112864075537141,0.958759422762995
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32464,0.012957486230067,0.00871971656220873,-0.00413315823186213,0.0300481306919961,0.137318848947808
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32464,0.0140075915247782,0.0085589236558552,-0.00276789884069798,0.0307830818902544,0.101751956997326
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32464,-0.0161393998609594,0.0125617638486355,-0.040760457004285,0.00848165728236628,0.198898054565488
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32464,-0.0198356694447046,0.010877311503433,-0.0411551999914333,0.00148386110202408,0.068252528501694
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32464,-0.00507377118440782,0.0159533701560919,-0.036342376690348,0.0261948343215324,0.750464722283078
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32464,-0.0212258542245675,0.00851833194544626,-0.0379217848376421,-0.00452992361149281,0.0127303473073746
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32463,0.00926477700670182,0.00943841190028306,-0.00923451031785297,0.0277640643312566,0.326324925783436
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32463,0.00439124332571518,0.0132225469135149,-0.021524948624774,0.0303074352762043,0.739820411662253
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32463,-0.00763052640711087,0.0281809281328913,-0.0628651455475777,0.047604092733356,0.786575552013554
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32463,-0.0207900780413284,0.0180977084371251,-0.0562615865780936,0.0146814304954368,0.250685734805333
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32463,-0.0145600695868395,0.0251956138854403,-0.0639434728023024,0.0348233336286235,0.563360624592857
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32463,-0.0314534658149087,0.0133961010772892,-0.0577098239263955,-0.00519710770342191,0.0189009036087652
LYZL2,Lysozyme-like protein 2,Mental health,X29171.Frequency of feeling 'in tune' with people,32370,-0.0865421073330077,0.0707096656695455,-0.225133052045317,0.0520488373793015,0.221023454047583
LYZL2,Lysozyme-like protein 2,Mental health,X29172.Freuency of feeling that lacks companionship,32444,-0.0246076978241862,0.0641823416261119,-0.150405087411365,0.101189691762993,0.701431230574059
LYZL2,Lysozyme-like protein 2,Mental health,X29173.Frequency of feeling left out,32391,-0.0234310018651847,0.0666106395900052,-0.153987855461595,0.107125851731225,0.72502710861881
LYZL2,Lysozyme-like protein 2,Mental health,X29174.Frequency of feeling isolated from others,32417,-0.0416844505339906,0.0693163287636517,-0.177544454910748,0.0941755538427667,0.547613670871233
LYZL2,Lysozyme-like protein 2,Mental health,X29175.Tendency to bounce back quickly after hard times,32481,-0.100496425958869,0.0579949382914617,-0.214166505010134,0.0131736530923956,0.0831610598738106
LYZL2,Lysozyme-like protein 2,Mental health,X29176.Ability to make it through stressful events,32481,0.0126085071898786,0.0564475049761714,-0.0980286025634174,0.123245616943175,0.823255606945822
LYZL2,Lysozyme-like protein 2,Mental health,X29177.Quick recovery from stressful events,32481,-0.0313689148336104,0.0574628724548862,-0.143996144845187,0.0812583151779666,0.585150655000183
LYZL2,Lysozyme-like protein 2,Mental health,X29178.Hard to snap back when something bad happens,32481,-0.0441804352113493,0.0565100625951147,-0.154940157897774,0.0665792874750754,0.434346152265338
LYZL2,Lysozyme-like protein 2,Mental health,X29179.Comes through difficult times with little trouble,32481,0.0289853096580246,0.057222595427874,-0.0831709773806084,0.141141596696658,0.61249427609741
LYZL2,Lysozyme-like protein 2,Mental health,X29180.Tendency to take a long time to get over setbacks,32481,-0.0295769898255244,0.0571375899797786,-0.14156666618589,0.0824126865348416,0.60472022026067
LYZL2,Lysozyme-like protein 2,Mental health,X29181.General happiness,32434,0.063790477547747,0.0597906686104279,-0.0533992329286916,0.180980188024186,0.286050689551298
LYZL2,Lysozyme-like protein 2,Mental health,X29182.Belief that own life is meaningful,32346,-0.0365310784149055,0.0591131106711051,-0.152392775330272,0.0793306185004606,0.536602361741878
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28809,-0.071811321943617,0.0737523508822028,-0.216365929672734,0.0727432857855004,0.330268620766234
LYZL2,Lysozyme-like protein 2,Health and medical history,X2946.Father's age,29651,-0.00146107193573608,0.00809578078522566,-0.0173288022747784,0.0144066584033062,0.856788080690799
LYZL2,Lysozyme-like protein 2,Health and medical history,X2966.Age high blood pressure diagnosed,29413,0.00506081709013235,0.0060316692793611,-0.00676125469741541,0.0168828888776801,0.401486797836011
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30000.White blood cell (leukocyte) count,46960,0.0150909109574419,0.0025849763639353,0.0100243572841287,0.0201574646307551,5.35790099788718e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46960,0.0141163896116968,0.00304954496212042,0.00813928148594076,0.0200934977374528,3.69459110865904e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30020.Haemoglobin concentration,46960,0.0130100387645763,0.00331830516402881,0.00650616064307987,0.0195139168860728,8.85580954885223e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30030.Haematocrit percentage,46960,0.0135500506455059,0.00321952707017864,0.0072397775879558,0.0198603237030561,2.57830165185637e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30040.Mean corpuscular volume,46960,-0.00370193458320916,0.00254629940551267,-0.008692681418014,0.00128881225159569,0.146002146296309
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46959,-0.00479040500016423,0.00255596344404723,-0.0098000933504968,0.000219283350168345,0.0609148205184195
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46959,-0.00241256808117019,0.00250185107184665,-0.00731619618198962,0.00249106001964924,0.334899271916411
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46960,-0.000495148145723183,0.00241052895482807,-0.00521978489718621,0.00422948860573984,0.837253214080917
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30080.Platelet count,46960,0.0229578782473208,0.00255343395720037,0.0179531476912081,0.0279626088034335,2.63902264805393e-19
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30090.Platelet crit,46960,0.0321527130401837,0.00261534361656114,0.0270266395517239,0.0372787865286435,1.26201623667988e-34
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46960,0.00703497223423321,0.00246922049009923,0.00219530007363872,0.0118746443948277,0.00438875506659774
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30110.Platelet distribution width,46960,0.00212944157979759,0.00247182502196623,-0.00271533546325622,0.0069742186228514,0.388979844456823
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30120.Lymphocyte count,46928,0.00452471752946272,0.00256913879825565,-0.000510794515118344,0.00956022957404379,0.0782214282200345
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30130.Monocyte count,46928,0.0108878121027562,0.00260999621595669,0.00577221951948111,0.0160034046860313,3.0362802884811e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30140.Neutrophill count,46928,0.0148664278940347,0.00256919802540066,0.00983079976424944,0.01990205602382,7.28623973875548e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30150.Eosinophill count,46928,0.00630614968010711,0.00252942412289917,0.00134847839922474,0.0112638209609895,0.0126698568013521
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30160.Basophill count,46928,0.0455585242309426,0.0368594274414215,-0.0266859535542435,0.117803002016129,0.216468739258117
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30170.Nucleated red blood cell count,46928,0.0239041138135697,0.160876676232596,-0.291414171602319,0.339222399229459,0.881881202535867
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30180.Lymphocyte percentage,46928,-0.00816685882655859,0.00253822385625396,-0.0131417775848164,-0.00319194006830083,0.00129474280273304
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30190.Monocyte percentage,46928,3.16190406971949e-05,0.0025805121000837,-0.00502618467546686,0.00508942275686125,0.990223865837405
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30200.Neutrophill percentage,46928,0.00693329575427142,0.00251632897761482,0.00200129095814637,0.0118653005503965,0.00586816606514863
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30210.Eosinophill percentage,46928,0.00171424561356366,0.00250031046113566,-0.00318636289026224,0.00661485411738955,0.492964187954972
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30220.Basophill percentage,46928,0.00258860325840147,0.0023982473611399,-0.00211196156943274,0.00728916808623568,0.280433100259427
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30230.Nucleated red blood cell percentage,46928,0.0250134902672221,0.160976255557765,-0.290499970625998,0.340526951160442,0.876518250302839
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30240.Reticulocyte percentage,46534,0.00895535284641371,0.00263352758051639,0.00379363878860158,0.0141170669042258,0.000673778393615511
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30250.Reticulocyte count,46534,0.0113870324264358,0.00272159565932055,0.00605270493416755,0.0167213599187041,2.87588283911342e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30260.Mean reticulocyte volume,46534,-0.00373600139815396,0.00251399945635587,-0.00866344033261146,0.00119143753630354,0.137272544645402
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30270.Mean sphered cell volume,46534,-0.00412580567386944,0.00254137019093417,-0.00910689124810042,0.000855279900361537,0.104505984556394
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30280.Immature reticulocyte fraction,46534,0.00221803380225923,0.00266258638329826,-0.00300063550900536,0.00743670311352382,0.404832696437175
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46534,0.00862928470309081,0.00270561526721234,0.00332627877935462,0.013932290626827,0.00142768361038172
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30300.High light scatter reticulocyte count,46534,0.0104220628816301,0.00277428568393827,0.00498446294111108,0.0158596628221491,0.000172634965037676
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30500.Microalbumin in urine,30961,0.00674062242716671,0.00496321588858848,-0.0029872807144667,0.0164685255688001,0.174473982101256
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,47015,0.00468862040370015,0.00264210602467063,-0.000489907404654293,0.00986714821205459,0.0759812495988405
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30520.Potassium in urine,46971,0.00299267337504724,0.00246494409701011,-0.00183861705509259,0.00782396380518706,0.224724634877507
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30530.Sodium in urine,46946,0.000588152220935135,0.00259561878992788,-0.00449926060732351,0.00567556504919378,0.820741344427257
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30600.Albumin,44608,0.00704986494346598,0.00272080083481393,0.00171709530723067,0.0123826345797013,0.00957388320055022
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30610.Alkaline phosphatase,46605,0.0115217332473698,0.00258050791054911,0.0064639377426935,0.016579528752046,8.04981536367954e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30620.Alanine aminotransferase,46613,0.00500699145676163,0.00269289394423307,-0.000271080673935192,0.0102850635874584,0.0629929389173435
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30630.Apolipoprotein A,44412,0.00570495729526859,0.00299022652989231,-0.000155886703320333,0.0115658012938575,0.0564226228312403
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30640.Apolipoprotein B,46511,0.0140581351883541,0.00256892534439243,0.00902304151334496,0.0190932288633633,4.48864248207489e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30650.Aspartate aminotransferase,46547,0.00339372776383027,0.00259631781724702,-0.00169505515797388,0.00848251068563443,0.191181793433366
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30660.Direct bilirubin,41671,-0.00822805894121798,0.0029839572290005,-0.014076615110059,-0.002379502772377,0.00583187304397951
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30670.Urea,46604,0.0010151384021174,0.00269966350215102,-0.00427620206209859,0.0063064788663334,0.706902617935171
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30680.Calcium,44611,0.0153448567255187,0.00261265486745761,0.0102240531853018,0.0204656602657356,4.33963647776904e-09
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30690.Cholesterol,46614,0.0137549094705495,0.00264357043160279,0.00857351142460806,0.018936307516491,1.97676475880993e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30700.Creatinine,46608,0.00163522310074383,0.00298930806964646,-0.00422382071576323,0.0074942669172509,0.58436778920542
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30710.C-reactive protein,46556,0.00900568576865055,0.0028147131562596,0.00348884798238174,0.0145225235549194,0.00137858590313757
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30720.Cystatin C,46611,0.00882613524485484,0.00291867410896757,0.00310553399127841,0.0145467364984313,0.00249723605891988
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30730.Gamma glutamyltransferase,46611,0.00834278840168299,0.00265111969171016,0.00314659380593108,0.0135389829974349,0.0016523421316032
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30740.Glucose,44587,0.00536012193171071,0.00282354442864119,-0.000174025148426028,0.0108942690118474,0.0576621146548271
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46528,0.0120994519570641,0.00288710564096103,0.00644072490078051,0.0177581790133477,2.78981348353325e-05
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30760.HDL cholesterol,44598,-0.000282697525228951,0.00314332379780469,-0.00644361216892615,0.00587821711846825,0.928339079458277
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30770.IGF-1,46487,0.00800281497104197,0.0025849644627538,0.00293628462404452,0.0130693453180394,0.00196456604049522
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30780.LDL direct,46564,0.012412773102852,0.00257198492613799,0.00737168264762153,0.0174538635580824,1.40129321964387e-06
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30790.Lipoprotein A,42193,0.00084856420832578,0.00283512183442235,-0.00470827458714203,0.00640540300379359,0.764711365963592
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30810.Phosphate,44571,0.00664551121720394,0.00281436616092948,0.00112935354178216,0.0121616688926257,0.0182213691145488
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30830.SHBG,44383,-0.0152159235398285,0.00296876784191397,-0.0210347085099798,-0.00939713856967707,2.99786669158568e-07
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30840.Total bilirubin,46532,-0.00574809006161927,0.00260299086215519,-0.0108499521514434,-0.000646227971795104,0.0272361375675644
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30850.Testosterone,42789,0.011044853870019,0.00462847643565996,0.00197304005612546,0.0201166676839125,0.0170297372221363
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30860.Total protein,44606,0.0143562013688413,0.00266643628470056,0.00912998625082824,0.0195824164868544,7.36466317691007e-08
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30870.Triglycerides,46606,0.0235669544823375,0.00285324993240247,0.0179745846148286,0.0291593243498463,1.5414837714342e-16
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30880.Urate,46585,0.0089910634320858,0.00317413681298937,0.00276975527862664,0.015212371585545,0.00462126684012481
LYZL2,Lysozyme-like protein 2,Blood and urine assays,X30890.Vitamin D,45316,0.00452790912850419,0.00282681924442148,-0.0010126565905619,0.0100684748475703,0.109222019849907
LYZL2,Lysozyme-like protein 2,Physical measures,X3137.Number of measurements made,45679,0.00241557731628847,0.040879588332095,-0.0777084158146177,0.0825395704471947,0.952880932256535
LYZL2,Lysozyme-like protein 2,Physical measures,X3143.Ankle spacing width,37599,-0.0124439832202203,0.00439168633074,-0.0210516884284707,-0.00383627801196993,0.00461068168122448
LYZL2,Lysozyme-like protein 2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37598,-0.00763125662292403,0.00356052215797933,-0.0146098800525635,-0.000652633193284535,0.0321075510880049
LYZL2,Lysozyme-like protein 2,Physical measures,X3146.Speed of sound through heel,37599,-0.00292936497667645,0.00343254780110114,-0.00965715866683469,0.00379842871348179,0.393448437113321
LYZL2,Lysozyme-like protein 2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37599,-0.00481667830643166,0.00347665921145367,-0.0116309303608809,0.00199757374801753,0.165943617956789
LYZL2,Lysozyme-like protein 2,Physical measures,X3148.Heel bone mineral density (BMD),37597,-0.00497991448748215,0.00346796519626326,-0.0117771262721581,0.00181729729719384,0.15103299154466
LYZL2,Lysozyme-like protein 2,Health and medical history,X3526.Mother's age at death,38298,-0.00325649592356239,0.00323665016640932,-0.00960033024972465,0.00308733840259986,0.314369864965545
LYZL2,Lysozyme-like protein 2,Health and medical history,X3581.Age at menopause (last menstrual period),37775,-0.00162373135735186,0.00319138296694789,-0.00787884197256973,0.00463137925786601,0.610910574560699
LYZL2,Lysozyme-like protein 2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29250,0.00132072764109084,0.00564357146237405,-0.0097406724251623,0.012382127707344,0.814976816407309
LYZL2,Lysozyme-like protein 2,Physical measures,X4100.Ankle spacing width (left),32004,0.00546476789708552,0.00602199675439066,-0.00633834574152018,0.0172678815356912,0.364188446560955
LYZL2,Lysozyme-like protein 2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32004,-0.00367549262549792,0.00488845237800975,-0.013256859286397,0.00590587403540118,0.452151203595657
LYZL2,Lysozyme-like protein 2,Physical measures,X4103.Speed of sound through heel (left),32004,-0.00405402213032932,0.00477205113239019,-0.0134072423498141,0.00529919808915546,0.395610864206091
LYZL2,Lysozyme-like protein 2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32004,-0.00393952684491146,0.00480922411524556,-0.0133656061107928,0.00548655242096984,0.412720647970734
LYZL2,Lysozyme-like protein 2,Physical measures,X4105.Heel bone mineral density (BMD) (left),32002,-0.00377634659208309,0.00479567451713368,-0.0131758686456651,0.00562317546149892,0.431044097563226
LYZL2,Lysozyme-like protein 2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32004,-0.00393817866409541,0.004808892433314,-0.0133636078333908,0.00548725050520003,0.412848351405984
LYZL2,Lysozyme-like protein 2,Physical measures,X4119.Ankle spacing width (right),32000,0.00616610902411191,0.00595889848619106,-0.00551333200882258,0.0178455500570464,0.300807947911106
LYZL2,Lysozyme-like protein 2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32000,-0.00293754926909942,0.00490109637840488,-0.012543698170773,0.00666859963257415,0.548947005899956
LYZL2,Lysozyme-like protein 2,Physical measures,X4122.Speed of sound through heel (right),32000,-0.00190198746758749,0.0047990002305068,-0.0113080279193808,0.00750405298420583,0.691872847149903
LYZL2,Lysozyme-like protein 2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32000,-0.00228227295997029,0.00482777968782951,-0.0117447211481161,0.00718017522817555,0.636414069792811
LYZL2,Lysozyme-like protein 2,Physical measures,X4124.Heel bone mineral density (BMD) (right),31997,-0.00236239440103249,0.00482029810882264,-0.0118101786943249,0.00708538989225988,0.624082335607457
LYZL2,Lysozyme-like protein 2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32000,-0.00228434042946249,0.00482778314512225,-0.0117467953939021,0.00717811453497712,0.636108791675557
LYZL2,Lysozyme-like protein 2,Physical measures,X4194.Pulse rate,32244,0.00569169282723032,0.00468903391889058,-0.00349881365379522,0.0148821993082559,0.224849210485604
LYZL2,Lysozyme-like protein 2,Physical measures,X4195.Pulse wave reflection index,32244,0.00129744034472446,0.00463816824279087,-0.00779336941114565,0.0103882501005946,0.779691168226981
LYZL2,Lysozyme-like protein 2,Physical measures,X4196.Pulse wave peak to peak time,32242,-0.00511060418029375,0.00423448263316831,-0.0134101901413036,0.00318898178071613,0.22750665963932
LYZL2,Lysozyme-like protein 2,Physical measures,X4198.Position of the pulse wave peak,32244,0.00435063041749848,0.00410943547635791,-0.00370386311616302,0.01240512395116,0.289772451717142
LYZL2,Lysozyme-like protein 2,Physical measures,X4199.Position of pulse wave notch,32244,0.00220949821851065,0.00458152218684862,-0.00677028526771264,0.0111892817047339,0.629632738487417
LYZL2,Lysozyme-like protein 2,Physical measures,X4200.Position of the shoulder on the pulse waveform,32244,0.00479075071843798,0.00410089767032107,-0.00324700871539132,0.0128285101522673,0.242753772627999
LYZL2,Lysozyme-like protein 2,Physical measures,X4269.Number of triplets attempted (left),32152,-0.315184987931742,0.152364451543003,-0.613819312956027,-0.0165506629074557,0.0386146059686546
LYZL2,Lysozyme-like protein 2,Physical measures,X4270.Volume level set by participant (left),32075,-0.112626963996968,0.0553549773685289,-0.221122719639285,-0.00413120835465175,0.041922546021389
LYZL2,Lysozyme-like protein 2,Physical measures,X4276.Number of triplets attempted (right),32153,-0.321569146773171,0.148858819958417,-0.613332433891668,-0.0298058596546742,0.0307857463248661
LYZL2,Lysozyme-like protein 2,Physical measures,X4277.Volume level set by participant (right),32066,-0.0910885554202203,0.0553643744905159,-0.199602729421631,0.0174256185811909,0.0999583749914352
LYZL2,Lysozyme-like protein 2,Cognitive function,X4288.Time to answer,32299,-0.00144501388818476,0.00528814292127341,-0.0118097740138806,0.00891974623751112,0.784664047306427
LYZL2,Lysozyme-like protein 2,Cognitive function,X4290.Duration screen displayed,32299,-0.000347224059291417,0.00463504013569879,-0.00943190272526105,0.00873745460667821,0.940285963270125
LYZL2,Lysozyme-like protein 2,Physical measures,X46.Hand grip strength (left),47649,-0.0129580892524093,0.00373828095385419,-0.0202851199219635,-0.00563105858285506,0.000528583806043365
LYZL2,Lysozyme-like protein 2,Physical measures,X47.Hand grip strength (right),47651,-0.0119221741990153,0.00373549515915593,-0.0192437447109609,-0.00460060368706969,0.00141679857441279
LYZL2,Lysozyme-like protein 2,Physical measures,X48.Waist circumference,47724,0.015316833507975,0.00498348984785221,0.00554919340618467,0.0250844736097653,0.00211797296741268
LYZL2,Lysozyme-like protein 2,Health and medical history,X4803.Tinnitus,32151,-0.0563103779313418,0.0673389314412795,-0.18829468355625,0.0756739276935659,0.403055301379622
LYZL2,Lysozyme-like protein 2,Working and living environment,X4825.Noisy workplace,32277,-0.0828316833754993,0.100072162783713,-0.278973122431576,0.113309755680578,0.407854605649754
LYZL2,Lysozyme-like protein 2,Working and living environment,X4836.Loud music exposure frequency,32225,-0.0473241063630308,0.109735494632108,-0.262405675841963,0.167757463115901,0.666294096794071
LYZL2,Lysozyme-like protein 2,Physical measures,X49.Hip circumference,47722,-0.00995257310417298,0.00423434170200408,-0.018251882840101,-0.00165326336824498,0.0187594490440459
LYZL2,Lysozyme-like protein 2,Physical measures,X50.Standing height,47718,-0.0119010145248439,0.00345598243502053,-0.0186747400974841,-0.00512728895220368,0.000575038927500433
LYZL2,Lysozyme-like protein 2,Health and medical history,X5057.Number of older siblings,31372,-0.0505258703678252,0.0573714109306027,-0.162973835791806,0.061922095056156,0.378521481078904
LYZL2,Lysozyme-like protein 2,Physical measures,X51.Seated height,47614,-0.0064599365696697,0.00347291648509673,-0.0132668528804593,0.000346979741119888,0.0628854868847566
LYZL2,Lysozyme-like protein 2,Eye measures,X5181.Ever had eye surgery,29752,-0.0584889484649568,0.142574123469045,-0.337934230464285,0.220956333534372,0.681649884305002
LYZL2,Lysozyme-like protein 2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29738,0.00238565584073319,0.00527946055825349,-0.00796208685344365,0.01273339853491,0.651377630132149
LYZL2,Lysozyme-like protein 2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29739,-0.00123715400581116,0.00525362498965301,-0.0115342589855311,0.00905995097390873,0.813840831032331
LYZL2,Lysozyme-like protein 2,Eye measures,X5190.Duration at which refractometer first shown (right),29674,0.000435866948842284,0.00529456446652996,-0.00994147940555644,0.010813213303241,0.934392642059658
LYZL2,Lysozyme-like protein 2,Eye measures,X5193.Duration at which refractometer first shown (left),29674,0.003526328920817,0.00532945793536212,-0.00691940863249276,0.0139720664741268,0.508213554645616
LYZL2,Lysozyme-like protein 2,Eye measures,"X5199.logMAR, initial (right)",29720,-0.0252021411678703,0.0706998934324575,-0.163773932295487,0.113369649959746,0.721505539513748
LYZL2,Lysozyme-like protein 2,Eye measures,X5200.Final number of letters displayed (right),29720,0.0413781478911321,0.552935517052073,-1.04237546553093,1.1251317613132,0.940349960961231
LYZL2,Lysozyme-like protein 2,Eye measures,"X5201.logMAR, final (right)",29677,-0.00515673182441596,0.00547610440354394,-0.0158898964553621,0.00557643280653016,0.346400609393434
LYZL2,Lysozyme-like protein 2,Eye measures,X5202.Number of rounds to result (right),29720,0.0491080317034366,0.0660497306009252,-0.0803494402743767,0.17856550368125,0.457211725623606
LYZL2,Lysozyme-like protein 2,Eye measures,"X5206.logMAR, initial (left)",29719,-0.0663656889480683,0.0699268243448525,-0.203422264663979,0.0706908867678426,0.342626834019158
LYZL2,Lysozyme-like protein 2,Eye measures,X5207.Final number of letters displayed (left),29719,0.189670190301119,0.4602473989984,-0.712414711735746,1.09175509233798,0.680279343359684
LYZL2,Lysozyme-like protein 2,Eye measures,"X5208.logMAR, final (left)",29666,-0.00570586550043048,0.00542787049863111,-0.0163444916777475,0.00493276067688649,0.293208013247126
LYZL2,Lysozyme-like protein 2,Eye measures,X5209.Number of rounds to result (left),29717,0.0179727885430347,0.0664464251982376,-0.112262204845511,0.14820778193158,0.786797464437879
LYZL2,Lysozyme-like protein 2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29474,0.0105780026428411,0.00544167479019837,-8.76799459476833e-05,0.0212436852316299,0.0519648204868108
LYZL2,Lysozyme-like protein 2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29474,0.0112545858029597,0.00545598018799546,0.000560864634488557,0.0219483069714308,0.0391831093826681
LYZL2,Lysozyme-like protein 2,Eye measures,X5256.Corneal hysteresis (right),29474,-0.00287081113817195,0.00540553869426074,-0.013465666978923,0.0077240447025791,0.595382003044469
LYZL2,Lysozyme-like protein 2,Eye measures,X5257.Corneal resistance factor (right),29474,0.00475079637203365,0.00539159862925682,-0.00581673694130972,0.015318329685377,0.378279885511625
LYZL2,Lysozyme-like protein 2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29466,0.0124681671297794,0.0054404795277894,0.0018048272553122,0.0231315070042467,0.0219618839063743
LYZL2,Lysozyme-like protein 2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29466,0.00845969054331247,0.00538624493099295,-0.00209734952143371,0.0190167306080587,0.116336347332345
LYZL2,Lysozyme-like protein 2,Eye measures,X5264.Corneal hysteresis (left),29466,-0.0094345090779376,0.00552340054852376,-0.0202603741530442,0.00139135599716896,0.0876800699159933
LYZL2,Lysozyme-like protein 2,Eye measures,X5265.Corneal resistance factor (left),29466,-0.00199967927562116,0.0054448896875228,-0.0126716630631659,0.00867230451192353,0.713442081893003
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29088,0.14701443331931,0.297493807437021,-0.43607342925725,0.73010229589587,0.621204989481211
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47648,-0.00494754566047346,0.0144126132193461,-0.0331962675703917,0.0233011762494448,0.731391782201265
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47648,-0.00412755753987703,0.0148943510050971,-0.0333204855098673,0.0250653704301133,0.781688630868309
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47648,0.00727006015077669,0.0384640687787578,-0.0681195146555885,0.0826596349571419,0.850087315193831
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47648,-0.00294802768752689,0.00630653201026358,-0.0153088304276435,0.00941277505258973,0.640177890719022
LYZL2,Lysozyme-like protein 2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47648,-0.000332014407519842,0.00576868920478545,-0.0116386452488993,0.0109746164338596,0.9541039359258
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35157,-0.00961671137837718,0.00740657484472269,-0.0241335980740337,0.0049001753172793,0.194177212360559
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35157,-0.0121762848966158,0.0183139526247629,-0.0480716320411511,0.0237190622479194,0.506151906840293
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35157,0.000621211698360201,0.0144701201362617,-0.0277402237687128,0.0289826471654332,0.965757614826453
LYZL2,Lysozyme-like protein 2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35157,0.0113181552589882,0.00891279857706553,-0.00615092995206024,0.0287872404700366,0.204156155781653
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47714,-0.00972388704023272,0.0117396831618063,-0.032733666037373,0.0132858919569076,0.407513582953299
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47714,-0.00972388704023272,0.0117396831618063,-0.032733666037373,0.0132858919569076,0.407513582953299
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47714,-0.00250452249769559,0.00953660785530142,-0.0211962738940864,0.0161872288986952,0.79284431012668
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47714,0.0156502695761407,0.0147114912678388,-0.0131842533088234,0.0444847924611049,0.287424651033362
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47714,0.0462352449113664,0.0371688492557192,-0.0266156996298433,0.119086189452576,0.213539859308393
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47714,0.0454469331755468,0.0253450523099256,-0.00422936935190742,0.0951232357030011,0.0729653810974047
LYZL2,Lysozyme-like protein 2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47714,-0.0351155799872872,0.0405333652844617,-0.114560975944832,0.0443298159702578,0.38631396639756
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47648,-8.22455905809807e-05,0.00767180700039975,-0.0151189873113645,0.0149544961302025,0.991446536304853
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47648,-0.00231526682622061,0.0127976652132203,-0.0273986906441325,0.0227681569916913,0.856437272343363
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47648,0.00552637083502473,0.00680166546730252,-0.00780489348088821,0.0188576351509377,0.41651163724448
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47648,0.00516021091099735,0.0125212813513936,-0.0193815005377342,0.0297019223597289,0.680258764694131
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47648,-0.000852632741369105,0.0121738835159547,-0.0247134444326404,0.0230081789499022,0.944164129960219
LYZL2,Lysozyme-like protein 2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47648,-0.00101143952750496,0.00685500100512019,-0.0144472414975405,0.0124243624425306,0.882701026942839
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30652,0.00728799134928369,0.0261909488276613,-0.0440462683529325,0.0586222510514999,0.780819188556141
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30652,-0.0071620148084905,0.0170814063198428,-0.0406415711953823,0.0263175415784013,0.675020785560052
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30652,-0.000819193063809417,0.0215549628821396,-0.043066920312803,0.0414285341851842,0.969685041149792
LYZL2,Lysozyme-like protein 2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30652,0.00935472124299435,0.0193161082963579,-0.0285048510178672,0.0472142935038559,0.628192654277928
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47640,-0.00700702227092825,0.0185929457987923,-0.0434491960365612,0.0294351514947047,0.706277711073268
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47640,-0.0179397632638006,0.0333039818438254,-0.0832155676776985,0.0473360411500972,0.590121668071367
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47640,-0.00802035575550929,0.0528913021595912,-0.111687307988308,0.0956465964772894,0.879473414428437
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47640,0.04626675091903,0.0503564203986136,-0.0524318330622526,0.144965334900313,0.358217314088064
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47640,-0.00949454762267404,0.0157610120823265,-0.040386131304034,0.0213970360586859,0.546908989539429
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47640,-0.00935291481499673,0.0224016689858855,-0.0532601860273323,0.0345543563973389,0.676309472956423
LYZL2,Lysozyme-like protein 2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47640,0.0107487504206822,0.0110526714250993,-0.0109144855725125,0.0324119864138769,0.330810773823118
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32439,0.011839084017042,0.0167288528645558,-0.0209494675974874,0.0446276356315713,0.479149448323213
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32439,-0.0243600222144265,0.0192172488765206,-0.0620258300124068,0.0133057855835538,0.20497336960765
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32439,-0.016537637538048,0.0251299482486275,-0.0657923361053579,0.0327170610292619,0.510502594706449
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32439,0.0110814950071555,0.00872751984927636,-0.00602444389742619,0.0281874339117371,0.204221847736885
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35366,-0.00844313951180049,0.00876700157951576,-0.0256264626076514,0.0087401835840504,0.335539267433703
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35366,0.0121075249194788,0.00765287932146293,-0.00289211855058857,0.0271071683895461,0.113658566838812
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35366,0.00172726695586146,0.00719365202333241,-0.0123722910098701,0.015826824921593,0.810249581140109
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35366,0.00863658099507238,0.0171271455128223,-0.0249326242100594,0.0422057862002041,0.614086950028083
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35366,-0.0040298727898026,0.0102633771026692,-0.0241460919110342,0.016086346331429,0.694588712179492
LYZL2,Lysozyme-like protein 2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35366,0.00695457799539336,0.0120654237096046,-0.0166936524754318,0.0306028084662185,0.564352935325269
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47648,-0.000631705446263385,0.0167866539081195,-0.0335335471061777,0.0322701362136509,0.969981888377395
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47648,0.00872043933441972,0.0106904158761845,-0.0122327757829019,0.0296736544517413,0.414665821489718
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47648,0.0745883636293342,0.0430972944448055,-0.00988233348248456,0.159059060741153,0.0835190970195053
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47648,0.00476700037272366,0.0105692145867499,-0.0159486602173061,0.0254826609627534,0.651974358357817
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47648,-0.00563250781972351,0.012581331776189,-0.0302919181010539,0.0190269024616069,0.654382761396875
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47648,0.0186213866191534,0.014144197178248,-0.00910123985021275,0.0463440130885195,0.188006219214971
LYZL2,Lysozyme-like protein 2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47648,-0.00884765565505964,0.00505824944876485,-0.0187618245746387,0.00106651326451948,0.0802776829364004
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28106,0.00935579669524738,0.0174352958029476,-0.0248173830785299,0.0435289764690246,0.591575930210413
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28106,0.0154371326321298,0.0234919968902461,-0.0306071812727525,0.0614814465370122,0.5111431742415
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28106,0.0176901959963225,0.0154419388204152,-0.0125760040916912,0.0479563960843362,0.25203808795367
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28106,-0.00495782456867086,0.0138615745394299,-0.0321265106659535,0.0222108615286117,0.720613356898665
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47750,-0.00203460599628754,0.00576281681851805,-0.0133297269605829,0.00926051496800783,0.724048489269712
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47750,-0.00547792115163308,0.0155577748583155,-0.0359711598739315,0.0250153175706653,0.72476507329495
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47750,-0.00206632853756712,0.00563430625267409,-0.0131095687928083,0.0089769117176741,0.713815891735929
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47750,-0.00997247691127336,0.00561133019542009,-0.0209706840942967,0.00102573027175002,0.0755477703635039
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47750,0.00990032324693494,0.00809792864348062,-0.00597161689428708,0.025772263388157,0.221502714853126
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47750,-0.00170138553363681,0.00715989624612319,-0.0157347821760383,0.0123320111087646,0.812172402743175
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47750,0.00392196849724907,0.00601090512497692,-0.00785940554770569,0.0157033425422038,0.514100892042452
LYZL2,Lysozyme-like protein 2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47750,0.00869778441874102,0.0161909181312633,-0.023036415118535,0.040431983956017,0.591133611963907
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,40522,-0.0104251073657049,0.00601069250733725,-0.022206064680086,0.00135584994867608,0.0828615234411123
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,40522,0.00183388816561231,0.00664963122619623,-0.0111993890377323,0.0148671653689569,0.782714485405039
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,40522,0.00498989361096222,0.00667307693580104,-0.00808933718320782,0.0180691244051323,0.454612837364657
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,40522,0.00433349791465513,0.00847134636298676,-0.0122703409567989,0.0209373367861092,0.608974611442036
LYZL2,Lysozyme-like protein 2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,40522,-0.00802533510838482,0.00605304176408954,-0.0198892969660003,0.00383862674923069,0.18491317610147
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47548,-3.9377956329404e-05,0.0060678010308388,-0.0119322679767735,0.0118535120641146,0.994822094100249
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47548,0.0076387063282336,0.00490383615678314,-0.00197281253906136,0.0172502251955286,0.119318046063094
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47548,-0.00583624814777839,0.00535211939017298,-0.0163264021525174,0.00465390585696065,0.275523911711885
LYZL2,Lysozyme-like protein 2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47548,0.0222444005096644,0.011871759142351,-0.0010242474093435,0.0455130484286723,0.0609810871738659
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47559,0.00232938125229849,0.00554534176646279,-0.00853948860996858,0.0131982511145656,0.674444871141025
LYZL2,Lysozyme-like protein 2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47559,-0.000667035217321544,0.0100383923213099,-0.0203422841670889,0.0190082137324458,0.947021403922155
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47648,0.00348006578262223,0.00528516759009073,-0.00687886269395559,0.0138389942592001,0.51024981612732
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47648,0.0094925190970663,0.00600712263896005,-0.0022814412752954,0.021266479469428,0.114072271310675
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47648,0.0071701323718911,0.0078419192007241,-0.00820002926152814,0.0225402940053103,0.360550939800453
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47648,-0.00880965534855395,0.011431925403852,-0.0312162291401039,0.013596918442996,0.440940829962708
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47648,0.0216199693554292,0.0116316824626306,-0.00117812827132686,0.0444180669821852,0.0630803648402479
LYZL2,Lysozyme-like protein 2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47648,0.00485373420812968,0.0151783503494556,-0.0248958324768033,0.0346033008930627,0.74913792326762
LYZL2,Lysozyme-like protein 2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37599,-0.00481712765473945,0.0034766573685958,-0.0116313760971872,0.00199712078770831,0.165903901038809
LYZL2,Lysozyme-like protein 2,Physical activities,X864.Number of days or week walked 10+ minutes,47218,-0.0209197421913946,0.032894165656846,-0.0853923068788128,0.0435528224960236,0.524801584708139
LYZL2,Lysozyme-like protein 2,Physical activities,X874.Duration of walks,43798,-0.00166688542386411,0.00270246825029165,-0.00696372319443575,0.00362995234670752,0.537373176290431
LYZL2,Lysozyme-like protein 2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46303,-0.00343505258286707,0.0320890499917777,-0.0663295905667514,0.0594594854010173,0.914752279594489
LYZL2,Lysozyme-like protein 2,Physical activities,X894.Duration of moderate activity,41122,0.0054771640188651,0.0394310472464053,-0.0718076885840894,0.0827620166218195,0.889527010061666
LYZL2,Lysozyme-like protein 2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29389,-0.0242651444115395,0.00586005992266661,-0.0357508618599661,-0.012779426963113,3.51922974112415e-05
LYZL2,Lysozyme-like protein 2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46322,-0.0378164977897999,0.0332795073701185,-0.103044332235232,0.0274113366556324,0.255830995021029
LYZL2,Lysozyme-like protein 2,Physical activities,X914.Duration of vigorous activity,35942,-0.00665859917742143,0.00362104037396894,-0.0137558383104006,0.000438639955557694,0.0659610481205691
